Content area
Among the numerous compounds released as a result of human activities, endocrine-disrupting chemicals (EDCs) have attracted particular attention due to their widespread detection in human biological samples and their accumulation across various ecosystems. While early research primarily focused on their effects on reproductive health, it is now evident that EDCs may impact neurodevelopment, altering the integrity of neural circuits essential for cognitive abilities, emotional regulation, and social behaviors. These compounds may elicit epigenetic modifications, such as DNA methylation and histone acetylation, that result in altered expression patterns, potentially affecting multiple generations and contribute to long-term behavioral phenotypes. The effects of EDCs may occur though both direct and indirect mechanisms, ultimately converging on neurodevelopmental vulnerability. In particular, the gut–brain axis has emerged as a critical interface targeted by EDCs. This bidirectional communication network integrates the nervous, immune, and endocrine systems. By altering the microbiota composition, modulating immune responses, and triggering epigenetic mechanisms, EDCs can act on multiple and interconnected pathways. In this context, elucidating the impact of EDCs on neurodevelopmental processes is crucial for advancing our understanding of their contribution to neurological and behavioral health risks.
Full text
1. Introduction
Nowadays, one of the major challenges in research is investigating the effects of environmental pollutants on human health. Modern ecosystems (including water, air, soil, and biomass) are contaminated by a mixture of substances resulting from anthropogenic activity [1]. These contaminants include industrial chemicals, pesticides, pharmaceuticals, personal care product and food additives, heavy metals, and plastic-associated compounds, and much of our current knowledge about their effects derives from experimental studies using animal models (especially rodents) [2] (Figure 1).
Among the substances that have aroused interest are endocrine-disrupting chemicals (EDCs), which the World Health Organization (WHO) and the International Program on Chemical Safety (IPCS) define as “an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny or (sub)populations” [8].
EDCs comprise two important groups. The first includes the so-called “dirty dozen”, a list of twelve persistent organic pollutants (POPs) classified by the Stockholm Convention as hazardous to the environment and human health [9]. This group includes dioxins, polychlorinated biphenyls (PCBs), and dichlorodiphenyltrichloroethane (DDT), which are known to be persistent in the environment, bioaccumulate in the food chain, and disrupt endocrine functions, leading to adverse outcomes in development and reproduction [10].
The second group of “emerging contaminants” includes chemicals commonly found in personal care products [11,12] or food and beverage packaging, such as triclosan, parabens, and phthalates. They have importance in the chemical industry as they are added to materials to enhance their quality and confer specific properties (such as flame retardancy, plasticity, antimicrobial activity, or preservation) [13]. By imitating or inhibiting natural hormones, these compounds can also impair thyroid function and reproductive health [2]. Their health risks may extend beyond the disruption of classical nuclear hormone receptors to include membrane steroid hormone receptors, which can induce widespread effects across multiple tissues and organ systems by modulating diverse intracellular pathways through non-genomic signaling mechanisms [14].
Given their widespread use and increasing detection in aquatic environments, they are now recognized as emerging pollutants with substantial endocrine-disrupting potential [15].
Concerns about EDCs stem mostly from their detection in a variety of biological matrices, including those of particularly vulnerable populations [5,16,17,18]. These compounds were found in the serum, urine, amniotic fluid, cord blood, and breast milk of pregnant women [4,19,20], posing questions about their potential impact on the development of fetuses. The nature and extent of the effects depend on several factors, including the type of EDC, the dose, and the timing of exposure throughout critical developmental windows. In this context, exposures during the prenatal and early childhood periods are particularly concerning, as they may interfere with normal growth, resulting in permanent neurological, immunological, reproductive, and developmental abnormalities [21].
In vitro research on human peripheral blood mononuclear cells from both males and females showed EDCs’ ability to directly alter immune functions, pro-inflammatory responses, natural killer cell activity, and lymphocyte differentiation, including the expression of the scaffolding receptor for activated C kinase 1 (RACK1) gene, in a sex-dependent manner [22]. Recent evidence reported that the pesticides vinclozolin, atrazine, and cypermethrin, acting as EDCs, may downregulate RACK1 via anti-androgenic mechanisms (also mediating indirect effects), leading to a decrease in cytokine release and reduced immune cell surface marker expression, exerting a potential immunosuppressive effect [23].
Their documented immunomodulatory action necessitates additional examination, since it may lead to several detrimental health consequences, including an elevated risk of cancer. In this context, RACK1 emerges as a potential point of convergence between endocrine, immune, and oncogenic signaling pathways [24]. Notably, RACK1 is aberrantly expressed in several malignancies, including breast cancer [25]. This dual role highlights a plausible mechanism through which EDCs may elevate cancer susceptibility by targeting signaling hubs such as RACK1, thereby simultaneously impairing immune responses and altering the tumor microenvironment [26].
In rodent models, estrogen-mimicking chemicals such as certain phthalates and bisphenol A (BPA) potentially cause severe reproductive issues in females [27] and affect testosterone levels in males [28,29]. In particular, in utero exposure to BPA (0.5, 20, and 50 µg/kg/day) resulted in the inhibition of germ cell nest breakdown in F1 females, and fertility problems were also observed at low doses [30]. Exposure of adult male rats to 5 and 25 mg BPA/kg/day resulted in decreased testosterone levels, diminished sperm production, and alterations in particular functional parameters [31].
Dietary and lifestyle decisions also contribute to the EDC burden. For instance, daily exposure can occur through the ingestion of contaminated food or the use of personal care products, but unhealthy behaviors such as alcohol consumption and smoking can exacerbate the effects by altering detoxification and metabolic pathways [32]. However, detoxification efficiency and overall resilience to these chemicals could be influenced by genetic factors, which may define individual susceptibility [33].
Over the past few decades, significant knowledge has been acquired by using in vitro and in vivo models in experimental studies. Early investigations on animals revealed serious reproductive impairments linked to PCBs and pesticides, such as DDT, historically associated with the environmental crisis known as the “silent spring”, described by R. Carson in the 1960s [6,34,35,36,37,38]. These early findings provided a foundation for subsequent research exploring broader effects on the immune system, metabolism, and neurodevelopment [18,39,40,41]. This body of work revealed the intricate relationships between biological systems and EDCs, with growing evidence of their involvement in epigenetic changes [42,43,44,45].
The endocrine system is directly involved in shaping the central nervous system, and hormones influence neuronal plasticity and the formation of circuits that are responsible for defining the animal’s basic behaviors [46,47].
In particular, the initial phases of development are easily influenced by external factors, including chemical exposure. EDCs can interfere with the proper formation of neuronal circuits and brain structure, with significant effects on cognitive functions and behaviors. Furthermore, it has been extensively demonstrated that early-life stressors can have durable effects on the individual, increasing the risk for the development of neurological disorders later in life [48]. EDCs can act through numerous mechanisms, including the dysregulation of hormonal pathways in both the fetus and the mother [49], also inducing epigenetic alterations [50].
At this point, a key question is how EDCs modulate the development of the central nervous system and which of these changes may be heritable. All this has a profound importance and would demonstrate how environmental chemical contamination can shape biological outcomes not only at the level of individuals but also across populations.
These investigations emphasize the intricate connections between biological systems and environmental chemicals, contributing to a more thorough understanding of EDC-related impacts across species. This is an integrative approach, in alignment with the One Health framework, which recognizes the interdependence of human, animal, and environmental health.
2. Targets of Endocrine-Disrupting Chemicals in Neurodevelopmental Processes
A balanced hormonal milieu is crucial for optimal brain development, and the synchronized maturation of endocrine, neuronal, and immunological systems facilitates the establishment of a healthy brain architecture and enduring cognitive and behavioral functions. The endocrine system regulates neurogenesis, brain maturation, and immune system development through precise hormone communication [51]. Processes such as microglial activation and immune cell differentiation are indispensable for shaping neural circuits, regulating synaptic pruning, and maintaining central nervous system homeostasis [52].
EDCs can interfere with any component of this interconnected system—hormonal, neural, or immune—potentially triggering problems on multiple fronts (Figure 2).
One of the main ways in which a developing fetus is exposed to EDCs is these substances passing through the placental barrier, putting the baby at risk of developing problems, including later in life. Current knowledge on the placental transfer of EDCs remains limited. Due to their lipophilic properties, certain EDCs can easily pass through the placenta and reach the developing fetus [54,55,56]. While passive diffusion has been documented [56], evidence also suggests that transport mechanisms may depend on the physicochemical properties of individual EDCs [57].
Regarding the direct effects on placental structures, a substantial body of knowledge has been derived from studies employing rodent experimental models.
For instance, placental samples from C57BL6J mouse dams fed 200 μg/kg/day of BPA and bisphenol S (BPS) for 2 weeks before mating (and continuously until E12.5) exhibited altered placental organization and dysregulated expression of genes critical for the spongiotrophoblast and trophoblast giant cell development. Moreover, the lower neurotransmitter levels (including 5-hydroxytryptamine) during critical stages of brain development resulted in behavioral abnormalities [58].
The presence of organochlorine and organophosphorus pesticides in brain samples from stillbirths from Northeast Italy provided remarkable proof of the placental transfer of hazardous substances in humans [56]. Moreover, the early expression of hormone receptors in the brain, by the end of the first trimester in humans and mid-embryonic development in rodents, renders the developing nervous system responsive to hormonal stimulations and EDC exposure [59,60]. Such receptors are involved in different key processes, including neural cell differentiation and migration, synaptogenesis, and myelination [61].
The aryl receptor (Ahr) has been shown to play a crucial role in the very early stages of neurodevelopment [62], and the related pathways were among the first identified targets of EDCs’ activity [63]. It contributes to neural circuit formation, synaptic plasticity, learning and memory, and defense against xenobiotic-induced neurotoxicity [62]. The function of AhR has been primarily elucidated through binding assays involving the persistent environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) [64], and other studies have contributed to shedding light on its activity. For example, early exposure of zebrafish to TCDD at an approximate concentration of 10 ng/mL for 1 h starting at 4 h post-fertilization revealed its ability to induce abnormalities in the development of specific brain regions, impairing morphogenesis, and different signaling pathways regulated by the AhR [65].
Estrogen receptors (ERs) are also required in neural proliferation, differentiation, synaptic plasticity, or protection against neuroinflammation and neurodegeneration [66,67,68,69]. PCBs, pesticides, heavy metals, and 4-nonylphenol have all been shown to bind to them [53].
EDCs also target the hypothalamus–pituitary–thyroid (HPT) axis [70], with obvious consequences for neuronal thyroid-hormone-dependent processes [47]. Exposure to polybrominated diphenyl ether (PBDE) flame retardants, specifically the congeners BDE-47, BDE-99, and BDE-100, has been linked to a heightened risk of thyroid disease in U.S. women, with more pronounced effects noted after menopause, potentially attributable to modified estrogen levels that exacerbate PBDE-induced interference with thyroid signaling [71]. Likewise, per- and polyfluoroalkyl compounds (PFAS) have been associated with thyroid dysfunction. A longitudinal investigation in a PFAS-exposed population revealed that heightened serum PFAS levels were associated with raised thyroid-stimulating hormone (TSH) levels, suggesting possible hypothyroid consequences [72].
These data highlight the susceptibility of the HPT axis to EDC interference, potentially indicating consequences for neurodevelopmental outcomes. For instance, the biologically active form of the thyroid hormone triiodothyronine (T3) plays a pivotal role in neuronal development, the differentiation and maturation of astrocytes, oligodendrocytes, and microglia [73,74,75,76], and myelin deposition [77].
Maternal and congenital hypothyroidism is well-known to cause significant neurological damage and intellectual incapacity in offspring, including an increased autism risk [78,79]. Other thyroid dysfunctions, such as maternal hypothyroxinemia owing to iodine shortage, are risk factors for neurodevelopmental disabilities, particularly during the early parts of pregnancy [80]. The exposure of pregnant Wistar rats to 0.5 or 5 mg/kg of 4-OH-CB107 (a PCB metabolite) and 25 mg/kg of Aroclor 1254 (a mixture of parent PCB congeners) from gestational day 10 to 16 resulted in a substantial drop in plasma thyroid hormone levels in offspring by postnatal day 4. Neurochemical analysis revealed that Aroclor 1254 disrupted both dopaminergic and serotonergic neurotransmission, while 4-OH-CB107 primarily affected the dopaminergic and noradrenergic systems, with minimal effects on serotonin signaling [81].
In addition to processes such as neuronal proliferation, migration, differentiation, synaptogenesis, and myelination, thyroid hormones play a role in photoreceptor maturation in the retina and are essential for neural circuit formation in the visual cortex [82,83,84]. Certain azole pesticides and PCBs can disrupt thyroid-hormone-mediated pathways, leading to interference with eye growth and vision processing, resulting in visual impairment, and altered ability to traverse the environment, identify social cues, and interact socially. In zebrafish models, larvae exposed to common azoles such as climbazole (0.1 and 10 μg/L) and triadimefon (50 and 500 μg/L) [85], and embryos exposed to PCBs at concentrations ranging from 0.125 to 2.0 mg/L [86,87,88], exhibited impaired retinal development and morphological alterations in photoreceptor cells [89,90], ultimately compromising visual function and behavior [91]. Also, BPA can act as an antagonist for thyroidal hormone receptors by modifying the expression of target genes such as RC3/neurogranin (the rat homolog for human neurogranin) [92], which is involved with the development of synaptic circuits and serves as a biomarker of cognitive activity [93].
The brain’s susceptibility to hormones and EDCs also depends on the expression of hormone-metabolizing enzymes, whose presence is influenced by the developmental stage of the fetus and sex. Enzymes of particular relevance include aromatase, monoamine oxidases (MAO), enzymes involved in thyroid hormone metabolism (such as thyroid peroxidase and deiodinases), acetylcholinesterase, and UDP-glucuronosyltransferase (UGT). They represent potential targets for EDCs, and their disruption may contribute to neurodevelopmental defects and behavioral alterations. Considerable insights have been garnered from teleosts, particularly zebrafish, where the significant expression and activity of aromatase B in the brain [94] modulate neurogenic processes, influencing behavioral patterns and locomotor capabilities [95].
MAOs are crucial for mood regulation, cognitive functions, and emotional responses [96,97], and EDC-induced disruption of monoamine metabolism may lead to altered neurotransmitter levels and behavioral effects [98,99,100].
The disruption of neurotransmitter catabolism may be another mechanism. The inhibition of AChE can lead to acetylcholine accumulation, potentially causing neurodevelopmental and behavioral issues [101]. UGTs, which are involved in glucuronidation and xenobiotic metabolism in the brain, can be affected by dioxin-like compounds [102], altering steroid metabolism and then impacting neurodevelopment [103,104,105].
As previously stated, the normal growth and maintenance of the central nervous system is also regulated by the cross-talk between the endocrine and immune systems, known as the immune–neuroendocrine network (INEN) [106,107]. Recent evidence highlights that EDCs can interfere with the INEN, targeting key components of the network and contributing to neuroinflammation and increased vulnerability to neuropsychiatric and neurodegenerative disorders [108]. It is already well-established that xenoestrogens may contribute to the risk of neurological diseases such as multiple sclerosis, stroke, and Alzheimer’s disease, which are more prevalent in women, also suggesting a sex-dependent mode of action [109].
Buoso et al. (2025) provided valuable insights into the complex interplay between endocrine disruptors and the immune–neuroendocrine network by proposing a hypothesis centered on a common molecular target to explain the detrimental effects of BPA [108]. Specifically, BPA was shown to downregulate the abovementioned scaffolding protein RACK1, involved in key cellular processes, directly or indirectly through the hyperactivation of the hypothalamic–pituitary–adrenal (HPA) axis. This downregulation results in reduced neuronal production of mature brain-derived neurotrophic factor (BDNF) [110], which is associated with anxiety-like behavior, increased neuroinflammation [110], and oxidative stress.
The G protein-coupled estrogen receptor (GPER), a seven-transmembrane domain receptor, has a particular relevance in this context, due to its ability to crosstalk with nuclear receptors, such as AhR and ERs [111,112], and bind environmental EDCs, including 17α-ethynylestradiol (EE), BPA [113] and pesticides [23].
GPER is broadly expressed in the HPA axis as well as in brain regions implicated in behavioral control [114]. Notably, a GPER deficiency in the rat model has been associated with phenotypic alterations, including dysregulated basal and stress-induced glucocorticoid responses, increased anxiety-like behaviors, and deficits in learning and memory [115]. In vitro studies using human THP-1 monocytes further demonstrated that BPA-mediated GPER activation leads to RACK1 up-regulation. These findings also suggested the involvement of the NF-κB signaling pathway in BPA-induced immunomodulatory responses, reinforcing GPER’s role in neuroimmune and endocrine homeostasis [116].
Also, BPA exposure was found to stimulate pro-inflammatory cytokines production by microglia and to affect neuronal activity through glucocorticoid receptors (GRα) expressed in the astrocytes [117], further contributing to BPA’s disruptive effects on neurodevelopment and neuroimmune regulation [117]. In particular, the study in E15.5 mouse embryos by Takahashi et al. (2018) revealed that BPA exposure significantly increased microglial numbers in the dorsal telencephalon and hypothalamus and altered the expression of microglial markers (Iba1, CD16, iNOS, CD206), inflammatory cytokines (TNFα, IL-4), signaling molecules (Cx3Cr1, Cx3Cl1), and neurotrophic factor IGF1 [118].
These data imply that BPA inhibits microglial growth and neuroinflammatory pathways during brain development, indicating prospective targets for neurodevelopmental toxicity assessment.
Since neuroinflammatory phenomena can significantly influence the integrity of the blood–brain barrier (BBB) [119] by triggering microglial activation and the release of pro-inflammatory cytokines, EDCs may increase BBB permeability, facilitating the entry of peripheral immune cells and other harmful substances into the brain, thereby exacerbating neurodevelopmental and neurodegenerative risks. A 6-week oral exposure of two-month-old C57BL/6J males to di(2-ethylhexyl) phthalate (DEHP) alone (5 and 50 μg/kg/day) or in an environmental phthalate mixture enhanced the permeability of the BBB due to the affection of the endothelial accessory tight junction protein zona occludens-1 and caveolae protein Cav-1 in the hypothalamic medial preoptic area and the hippocampal CA1 and CA3 areas [120].
3. The Epigenetics of Endocrine Disruptors in Nervous and Neuroendocrine Systems
The concept of endocrine interference includes the ability of certain substances to induce epigenetic changes, i.e., alterations in gene expression that occur without modifying the DNA sequence itself. These processes include methylation, modifications in histones, or gene silencing via noncoding RNAs and can be triggered by various factors, including exposure to xenobiotics. Establishing a direct cause-and-effect correlation between environmental pollutants and health outcomes is challenging in both experimental and epidemiological studies, as the effects are generally cumulative and may manifest years after the initial exposure.
A wide range of substances, including metals (cadmium, arsenic, methylmercury, nickel, and chromium), peroxisome proliferators (trichloroethylene, dichloroacetic acid, and trichloroacetic acid), air pollutants (particulate matter, black carbon, and benzene), and also EDCs (diethylstilbestrol, BPA, persistent organic pollutants, and dioxins), have been shown in in vitro and in vivo experiments to induce epigenetic modifications [121]. Such changes may contribute to the transmission of potentially harmful conditions to future generations (even in the absence of continued exposure to the initial chemical trigger). Notably, epigenetic phenomena within the brain (associated with behavioral and reproductive dysfunction) have advanced our comprehension of EDCs’ role in influencing gene expression [122], complementing information from cancer research on EDC-induced epigenetic changes [7,123]. Although the literature contains little knowledge on how EDCs can act directly on the genome, there is evidence that their exposure is linked to the altered expression of certain epigenetic regulators, such as DNA methyltransferases (DNMTs), methyl-CpG-binding proteins, and histone deacetylases (HDACs), producing outcomes that depend on sex, dose, and the timing of exposure [124].
3.1. Mechanistic Insights into Endocrine Disruptors’ Epigenetic Perspective
The HPA axis is a good illustration of how EDCs can cause epigenetic remodeling due to its involvement in neuroendocrine homeostasis [125]. Evidence has suggested that the offspring phenotype can be profoundly influenced by parental exposure to stress [126,127,128]. In particular, in several human studies, increased maternal stress and cortisol levels have been correlated with neurodevelopmental outcomes in offspring, including increased attention deficit hyperactivity disorder and autistic traits, increased anxiety-related symptomology, and reduced IQ and memory [129,130,131]. In this respect, animal model studies have provided important insights by explaining the underlying mechanisms, mostly connected to epigenetic alterations of genes implicated in HPA axis development and related behaviors. According to research by Grundwald et al. (2015) in rats, the effects of maternal stress during pregnancy can be transferred to F2 generations in a sex-dependent manner [132]. In females, increased HPA responses were linked to alterations in glucocorticoid negative feedback sensitivity, with decreased hippocampal glucocorticoid (GR) and mineralocorticoid (MR) receptor mRNA expression and increased corticotropin-releasing hormone (CRH) expression in the PVN. In F2 males, increased hippocampal Gr expression and attenuated HPA reactivity led to acute stress [133]. Also, adult male mice’s exposure to glucocorticoids before mating resulted in altered offspring behavior, with impairments in fear extinction and memory in females and increased anxiety in males [133,134].
Recently, a study by Di Criscio et al. (2023) on mice revealed that in utero exposure to human-relevant EDCs could alter DNA methylation in the HPA-axis-related genes Nr3c1, Nr3c2, and Crhr1, encoding GR, MR, and CHR receptor 1, respectively. These changes correlated with hyperactivity and decreased social behavior [135].
The modification of DNA methylation by EDCs has been documented in numerous studies. Through these mechanisms, BPA may influence synapse formation and maturation, with potential long-term consequences and the development of nervous system disorders across generations [136].
In the mouse model, maternal exposure to low doses of BPA at 20 µg/kg of body weight administered once daily by means of subcutaneous injection from E0 resulted in hypo- and hyper-methylation events in the fetal forebrain mediated by de novo methyltransferases (Dnmt 3a and 3b) [137].
BPA exposure increased basolateral amygdala Dnmt1 expression and decreased glutamic acid decarboxylase (GAD67) in postnatal day 45 female rats, indicating a potential impact on anxiety-related behaviors [138]. BPA may also disrupt the timing of key neurodevelopmental processes, such as the transition to increased expression of the chloride transporter KCC2 via the epigenetic downregulation of its expression, an effect reversible by HDAC inhibitors [136].
Additionally, BDNF, a critical neurotrophin for synaptic plasticity and neurodevelopment, has been identified as a target of EDC-induced epigenetic modifications. Administration of PCBs at 1 mg/kg to pregnant rats via intraperitoneal injection on E16 and E18 led to significant changes in offspring gene expression, affecting regulators of hypothalamic development, including BDNF and genes encoding GABAB receptor subunits [139].
However, epigenetic alterations can be mediated by microRNA (miRNA), short noncoding endogenous RNA transcripts. Some modifications in microRNA levels may also exhibit variability across both sex and brain regions, as observed in the offspring of exposed pregnant rat dams [140].
Phthalate exposure was associated with modified miRNA expression, leading to different health conditions, such as neurodevelopmental outcomes. For instance, maternal urine concentrations of phthalate metabolites were correlated with detrimental cognitive and behavioral development in children, exhibiting sex-specific effects [141].
Research conducted on rodent and zebrafish models revealed modifications in the expression of miRNA related to BDNF, cAMP response element binding protein (CREB) [142], synapsin-1, and PSD95 [143]. In particular, to study hippocampus pubertal effects, 5-week-old male C57BL/6 mice were exposed to DEHP, 0.5, 5, and 50 mg/kg/day for 28 days. DEHP decreased miR-93 and increased TNFAIP1, resulting in CK2β degradation and inhibition of the Akt/CREB pathway, leading to neuronal death (via downregulation of Bcl-2). Learning and memory impairments were also discovered [143].
As discussed in the previous section, inflammatory processes play a central role in the mechanisms underlying neurodevelopmental disruptions. Emerging evidence indicates that EDC exposure can induce epigenetic modifications in genes regulating inflammation. For example, studies in human myeloid dendritic cells have demonstrated that exposure to nonylphenol and 4-octylphenol could alter T-cell cytokine responses through pathways involving estrogen receptors, the MKK3/6-p38 MAPK signaling cascade, and histone modifications [144]. Additional findings in human monocytes have shown that these same compounds could modulate chemokine expression by altering histone H4 acetylation [145].
Early BPA exposure induces long-term epigenetic and inflammatory alterations in immune cells. Prenatal exposure to BPA was found to enhance the production of pro-inflammatory mediators (CysLTs, PGD2, TNFα, IL-13) and reduce global DNA methylation levels in bone-marrow-derived mast cells (BMMCs) of adult mice [146].
These observations suggest a plausible hypothesis: if EDCs can drive the epigenetic reprogramming of inflammatory gene networks, they may contribute to neurodevelopmental processes where inflammation plays a critical role, potentially participating in the pathogenesis of neurodevelopmental and neurodegenerative disorders.
3.2. Endocrine Disruptors, Microbiota, and Epigenetic Changes: A Warning Triangle for Neuromodulation
Emerging studies suggest that EDCs may contribute to inflammatory conditions in the digestive system by interfering directly or indirectly with different pathways regulating the immune responses and gastrointestinal functions [147,148]. The intestinal immune system, with innate and adaptive components, plays a crucial role in protecting the host from external stressors, including chemical contaminants [149]. By regulating tolerance to dietary antigens and commensal microbiota while mounting defenses against pathogens and xenobiotics, it serves as a first line of defense against chemical stressors, which can otherwise compromise gut homeostasis and overall health.
To understand the ability of EDCs to interfere with proper immune system function, both in vitro and in vivo models have been employed, providing valuable insights into the underlying mechanisms of their immunomodulatory effects. Several studies have shown the ability of certain compounds, such as BPA, to interfere with the differentiation and proliferation of immune cells [108,150,151,152] and modulate histamine release [153].
Perinatal exposure to BPA in rats can reduce the population of helper T cells (Th), regulatory T cells (Treg), and dendritic cells (DC) in the mesenteric lymph nodes and spleen, impacting the appropriate production of cytokines [154].
Certain ECDs have been shown to alter the intestinal microbiota, which can exacerbate intestinal inflammation, increasing gut permeability and enhancing susceptibility to infections [155].
Additionally, intestinal bacteria can metabolize EDCs, leading to the production of equally or more toxic by-products, further altering microbiota composition and function [147]. All of this has significant neurological implications, as dysbiosis has been associated with the onset of neurobehavioral diseases [156].
According to the established theory of the “gut–brain axis”, brain function and behavior are intimately connected to gut microbiota health through bidirectional communication [157] mediated by immune signaling, hormones, and the vagus nerve [158]. Mediators synthesized by the gut microbiota [159], once released into the bloodstream, can impact neuronal activity and potentially trigger cognitive impairments [160]. Importantly, there is growing but still emerging evidence that microbiota-derived metabolites can act as epigenetic regulators, such as short-chain fatty acids (SCFAs), which can influence histone acetylation and DNA methylation, altering chromatin accessibility [161,162,163]. In particular, bacterial butyrate has been linked to altered DNA methylation patterns associated with neurodegenerative diseases and depressive-like symptoms [164].
Dietary nutrients processed by the gut microbiota serve as substrates to generate metabolites involved in epigenetic regulation [165]. For example, choline acts as a donor of methyl groups in methylation reactions, and its bioavailability is influenced by both diet and gut flora composition [166]. In rodents, deficits in maternal choline have been associated with changes in the cholinergic system and changes in the DNA methylation within the offspring’s hippocampus [167,168], a critical brain region involved in memory, creativity, decision-making, social behavior, and other cognitive functions, whose alterations can result in rigid and maladaptive behaviors [169].
Gut microbiota can influence brain neurotransmitter levels, affecting brain function and cognition. Animal studies have demonstrated that the gut microbiota can modulate neurotransmitter systems, with germ-free and antibiotic-treated mice exhibiting altered neurotransmitter levels and receptor expression in the brain [170].
In this context, the relationship between dietary exposure to EDCs and detrimental effects on the nervous system may represent another key point due to their ability to impact the microbiota. It was reported that long-term BPA exposure in women results in a pro-inflammatory gut microbiota and a decrease in Bacteroidales and Lactobacillus [171], with the latter genus appearing to exert a protective role against EDC-induced oxidative stress [172]. A study by Kong and colleagues further supported the role of the gut–brain axis by showing that daily consumption of Lactobacillus reduced autistic-like behaviors in rats treated with valproic acid during sexual maturation and weaning by resolving disruptions in 5-hydroxytryptamine metabolism [173].
However, in the rodent model, parental exposure to BPA and ethinyl estradiol (EE) was shown to affect the gut microbiota, leading to later behavioral and metabolic disruptions in F1 offspring, highlighting the transgenerational issues of dysbiosis [174].
It is essential to consider the gut–brain axis as a comprehensive network without neglecting the HPA axis, whose dysregulation can also be associated with alterations in the nervous system [175].
For example, in response to stress, activation of the HPA axis leads to the release of CRH, adrenocorticotropic hormone (ACTH), and GC, which can directly influence gut physiology by altering intestinal permeability, motility, and immune responses [176]. These hormonal signals also modulate gut microbiota composition and activity, creating a feedback loop in which gut-derived signals, including microbial metabolites and inflammatory cytokines, can in turn influence HPA axis function. For example, the gut microbiome’s enzymatic repertoire comprises 11β-hydroxysteroid dehydrogenase type 1, which modulates glucocorticoid levels and is influenced by several EDCs [177].
Therefore, considering that EDCs can interfere with the health of our gut microbiota, it is reasonable to propose a mechanistic link between EDCs, microbiota dysregulation, and epigenetic modifications (Figure 3). Understanding this complex interaction is critical for elucidating how environmental chemicals influence neurodevelopment and behavioral outcomes across generations.
4. From Individual Behavior to Population Dynamics: New Challenges for Behavioral Endocrinology
One important consequence of aberrant neurodevelopment is the emergence of behavioral alterations, highlighting the need to identify the temporal windows of susceptibility to toxic exposures, particularly during gestation. Early-life exposure can result in transgenerational effects, as fetal exposure also impacts the developing germ cells. Epigenetic modifications triggered during this period may lead to heritable increases in neurological disease susceptibility, behavioral changes, and altered adaptability to environmental challenges across generations [28,178,179,180,181,182,183].
For instance, Tran and colleagues (2023) demonstrated that placental DNA hypomethylation resulting from exposure to the DEHP plasticizer in rodents primarily affected genes implicated in neurological disorders, including dementia and autism [182]. The inheritance of such behavioral phenotypes is often sex-dependent. For example, F3-generation rats, descendants of vinclozolin-exposed progenitors, exhibited sex-specific behavioral differences. Male offspring displayed reduced anxiety behavior, whereas females exhibited an increase [181,184,185]. These effects correlated with distinct genetic patterns, especially in the mRNA levels of genes encoding for hormone receptors (estrogen receptor α, Esr1, and androgen receptor, Ar) across different brain regions [186,187].
Similarly, Hatcher et al. (2019) revealed that multigenerational exposure to phthalates (DEHP) reduced anxiety in female F3 mice from high-dose backgrounds, with no effect in males. Moreover, sex- and dose-dependent changes in estrogen receptor gene expression were found in the amygdala, notably with reduced Esr1 mRNA in F3 females with ancestral DEHP exposure [188].
In the field of behavioral endocrinology, there is a growing interest in the intricate relationship between environmental factors and behavioral development. This perspective is driven by the organization/activation hypothesis, which posits that gonadal hormones can shape nervous system development, acting both during early life and adulthood. Indeed, EDC exposure can affect reproductive health and neurodevelopment, often in a sex-specific manner [189].
An interesting example comes from Carbone et al. (2019), who reported a dual effect following chronic DEHP exposure in the rat model. Adult males showed an increase in plasma levels of luteinizing (LH) and follicle-stimulating (FSH) hormones, reduced testosterone levels, and diminished hypothalamic GABA content. These changes were accompanied by anxiety-like behaviors, suggesting simultaneous modulation of endocrine and behavioral systems [190]. Similarly, in utero exposure to a human-relevant mixture of EDCs altered the methylation pattern of HPA axis genes in mice, with subsequent effects on behavior, such as increased hyperactivity and reduced sociability, in adult males [135].
Experimental models clearly show that EDCs can interfere with normal neurodevelopment, shaping primary behavioral responses. Studying these effects in humans requires epidemiological research, which presents unavoidable challenges due to the ubiquity of chemical exposure and mixture effects.
Nonetheless, past incidents raised public awareness, for example, the “Yu-Cheng Rice Oil Poisoning” episode in the late 1970s, in which approximately 2000 individuals were exposed to PCBs, polychlorinated dibenzofurans (PCDFs), and ter- and quaterphenyls via contaminated rice oil. In addition to skin and ocular lesions, developmental abnormalities, such as ectodermal defects, cognitive delays, and behavioral impairments, were observed in the offspring of exposed mothers; these effects persisted in children born up to six years after exposure [191].
Recent studies continue to link EDC exposure to neurodevelopmental abnormalities, such as altered internalizing and externalizing behaviors (including anger, anxiety, and depression) [192,193,194,195]. Thus, it would be more accurate to refer to EDCs as exogenous substances capable of interfering with normal neuroendocrine regulation at both the individual and population levels [196].
Beyond individual outcomes, EDC-driven behavioral changes can impact fertility and reproductive dynamics. For instance, women exposed to high levels of PCBs through the consumption of contaminated fish have exhibited shortened menstrual cycles [197], while other PCB congeners have been associated with a decreased gestation duration [198] and reduced couple fertility [199].
In wildlife, EDC-induced behavioral alterations may destabilize social structures essential for survival and procreation, perhaps impacting group cohesion and survival strategies. For example, the exposure of honeybee larvae to the hormone analog pyriproxyfen impaired social integration, impacting colony balance and population growth [200]. Similarly, EDC-driven changes in predator–prey dynamics can adversely affect the ecosystem equilibrium. In larval fish, the exposure to environmental estrogen estrone (E1) impaired anti-predator behavior, increasing vulnerability to predators, though paradoxically reducing predation success in piscivorous sunfish [201,202]. Changes in migratory activity [203], foraging, pollination, and seed dispersal may also result from EDC exposure, impairing ecosystem services and contributing to biodiversity loss [204,205,206].
In humans, EDC-driven behavioral alterations in humans may affect social functioning and mental health, contributing to the increasing prevalence of neurodevelopmental disorders [207], psychiatric conditions, and social relationship impairments. In Poland, early school-age children exposed to certain phthalates exhibited lower cognitive performance (as measured by the Intelligence and Development Scale) and lower behavior scores (Strengths and Difficulties Questionnaire) in association with a metabolite of dimethyl phthalate (MMP) and di-n-butyl phthalate exposure [208]. A French cohort study of 246 families found impaired verbal comprehension in six-year-old children exposed to greater concentrations of the PBDEs BDE 99 and BDE 209 after delivery [209]. Despite limitations in these studies, recent systematic reviews of epidemiological studies show links between early exposure to EDCs and the onset of autistic spectrum symptoms [210]. This reinforces the need to reframe research paradigms to better capture the role of environmental exposure in neurodevelopmental outcomes.
Given the multidimensional nature of EDC effects, Table 1 provides an integrated overview of the elements reported in the text, spanning from epigenetic mechanisms to behavioral alterations and ecological impacts.
5. Methodological Challenges and Translational Barriers in Endocrine Disruptor Research
A comprehensive analysis of the EDC literature highlights considerable methodological heterogeneity arising from differences in species, strains, developmental windows, exposure routes, and dosing regimens. This variability undermines reproducibility and poses significant challenges for drawing consistent conclusions across studies, even when examining the same compound. Biases inherent to animal models present major limitations for extrapolating EDC findings to humans, as species-specific differences in hormone receptor profiles, metabolism, placental structure, and neurodevelopmental timing can influence susceptibility. Rodents (e.g., rats and mice) and fish species (e.g., zebrafish and medaka) are primarily employed to investigate EDCs’ effects on neurodevelopment and behavior; however, the reliance on controlled, high-dose exposures in these models often fails to replicate the chronic, low-level exposures typical in human populations [211].
Toxicological studies must also recognize that experimental settings cannot replicate the multiple concurrent exposures experienced in real-world environments, where organisms are simultaneously exposed to diverse contaminants, thus limiting the ability to assess potential synergistic effects [212].
Another major point in EDC research is represented by non-monotonic dose–response relationships, wherein low doses elicit effects that are not predicted by high-dose exposures or even provoke opposite outcomes. These non-linear dynamics challenge the classical toxicological paradigm that “the dose makes the poison” and complicate risk assessment processes. Despite increasing recognition of this phenomenon, many studies continue to omit sufficiently low doses or fail to include adequate dose ranges to detect non-monotonic responses [213].
Also, epigenetic consequences, suggested as important mediators of transgenerational impacts, represent another area of ambiguity [214]. Most research on epigenetic inheritance has centered on DNA methylation, histone modifications, and small noncoding RNAs. Additional potential carriers (prions [215], maternally inherited proteins, the microbiome, lipids [216], and other regulatory RNAs) may also mediate transgenerational information transfer. The field is rapidly evolving, and it remains to be determined whether these diverse mechanisms converge into a unified epigenetic signaling system or function as interconnected yet distinct pathways of heritable non-genetic information.
Given the critical need to address the limitations inherent in extrapolating findings from animal studies to humans, enhancing the translatability of research on EDCs requires the integration of epidemiological data with animal and cellular models, alongside explicit consideration of interspecies differences and systematic evaluation of study quality. The incorporation of advanced in vitro systems utilizing human-derived cells, such as brain organoids, in conjunction with computational models of human exposure, can offer valuable complementary insights to those obtained from traditional animal studies [217].
To comprehensively assess the translational relevance of experimental models and their alignment with epidemiological data, we compared findings from animal studies and major human cohorts investigating the neurodevelopmental impacts of EDCs. In this context, the SELMA (Swedish Environmental Longitudinal, Mother and child, Asthma and allergy study), CHAMACOS (Center for the Health Assessment of Mothers and Children of Salinas), and ELEMENT (Early Life Exposure in Mexico to Environmental Toxicants) studies are examples of key longitudinal birth cohorts that examine early-life exposure to EDCs and their effects on child neurodevelopment.
Regarding the SELMA study (
Some investigations within the CHAMACOS cohort have extended assessments into adolescence, reporting no significant associations between prenatal phthalate exposure and neurodevelopmental scores—a notable contribution, as no prior studies had examined these relationships in this critical developmental period [220]. However, despite the importance of CHAMACOS, which has followed over 800 children and their mothers since 1999, discrepancies with findings from other studies highlight how such research can yield unexpected results, possibly reflecting inconsistencies between parent- and self-reported behaviors, with self-report reliability increasing as participants age.
The ELEMENT investigations have followed three birth cohorts recruited from maternity hospitals in Mexico City for over two decades to elucidate how maternal and early-life exposure to metals and environmental chemicals affects pregnant women and child health outcomes. Of particular interest, prenatal exposure to the organophosphate pesticide chlorpyrifos—known to exhibit endocrine-disrupting activity—was associated with an increased risk of attention deficit hyperactivity disorder symptoms in children [3]. However, it is important to acknowledge that these findings are derived from studies with relatively modest sample sizes, underscoring potential limitations and the need for cautious interpretation in this type of research.
Unlike animal models—which, despite being invaluable, have limitations in reflecting human physiology—these cohorts provide direct evidence of EDC impacts in human populations. However, the limitations of cohort studies such as ELEMENT, SELMA, and CHAMACOS may include potential confounding by socioeconomic and lifestyle factors, reliance on spot urine samples or single-time-point measurements that may not accurately capture long-term or fluctuating exposures, and modest sample sizes that limit statistical power for detecting subtle neurodevelopmental effects.
Additionally, real-world exposure usually involves complex mixtures of multiple EDCs that may interact synergistically or antagonistically, and disentangling these combined effects remains challenging both in human epidemiological research and in experimental animal models. Such complexities highlight the difficulty in extrapolating isolated chemical findings to real-life exposure scenarios, underscoring the need for advanced analytical approaches and mixture-focused studies.
Therefore, integrating findings from such studies is essential for accurately assessing the neurodevelopmental risks of EDCs and should complement animal data in the broader evaluation of these chemicals.
Future Directions and Research Priorities
To address these complex challenges, future research should embrace integrative, cross-disciplinary approaches that extend beyond traditional toxicological paradigms. A key priority involves the advancement of human-relevant experimental models, such as brain organoids or induced pluripotent stem cell (iPSC)-derived systems, which more accurately recapitulate human neurodevelopmental processes and reduce reliance on animal models with limited translational validity.
The extension and standardization of longitudinal cohort studies are equally important. These efforts should include frequent exposure assessments and standardized neurodevelopmental outcome measurements to improve reliability and allow for meaningful comparisons between studies. Strengthening the epidemiological framework will also allow for deeper interpretations of exposure–outcome correlations, particularly in terms of developmental windows of susceptibility.
Future research should concentrate on chemical combinations to identify additive, synergistic, or antagonistic interactions, recognizing that environmental exposures rarely occur in isolation. This calls for the incorporation of innovative computational techniques and mixture-oriented risk assessment frameworks that can handle the intricacy of exposures encountered in the actual world.
Simultaneously, as non-monotonic dose–response relationships contradict the traditional presumptions that support current safety standards, they ought to be investigated and included in regulatory risk assessments.
Thus, the successful mitigation of the dangers associated with EDCs necessitates concerted efforts from the public health, scientific, and regulatory domains. Developing well-informed policies and encouraging interdisciplinary collaboration will be essential to converting research findings into effective public health initiatives.
6. Conclusions
Environmental contaminants, particularly EDCs, exert effects that must be assessed not only in terms of acute or short-term damage but especially in terms of chronic exposure and transgenerational impacts.
Initial research focused on the reproductive effects and dysregulation of hormonal homeostasis, but it is now clear that the mechanisms of action can also involve epigenetic modifications and interference with proper neurodevelopment. Disruption of neurodevelopment affects the formation of brain circuits that govern cognitive activities and behavior.
To advance understanding of these complex effects, future research must go beyond the limitations of traditional toxicology by prioritizing robust experimental designs, comprehensive population-level studies, and systematic evaluations of study quality to better inform risk assessments and public health policies.
Conceptualization, A.D., G.C. and M.A.; writing—original draft preparation, A.D. and G.C.; review and editing, C.D., A.F. and C.M.; visualization, G.C. and A.D.; supervision, M.A. All authors have read and agreed to the published version of the manuscript.
The authors declare no conflicts of interest.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Figure 1 The unknown consequences of exposure to environmental contaminants. The population is exposed to a wide range of contaminants, the majority of which result from human activities (industrial production, agriculture, use of personal care products, etc.). These pollutants have been found in a variety of biological fluids, including those of pregnant women, raising worries about their potential consequences for unborn children [
Figure 2 Main targets of endocrine disruptors’ activity. The proper neurodevelopment of an individual can be influenced by the activity of endocrine disruptors at various levels [
Figure 3 Relationship between the gut–brain axis and endocrine-disrupting chemicals. The gut and the central nervous system interact through a comprehensive network, also including the immune system and the hypothalamic–pituitary–adrenal axis (and related receptors). All these elements connect two body regions, and the mediators produced and released by the gut bacteria can affect nervous system tissue. It has also been demonstrated that these compounds can cause epigenomic changes and modifications. Endocrine disruptors (including those given through food) can cause dysbiosis, interfering with the axis’s regular balance. Abbreviations: EDCs, endocrine-disrupting chemicals; HPA, hypothalamic–pituitary–adrenal axis.
Effects of endocrine-disrupting chemicals across epigenetic, neurodevelopmental, behavioral, and ecosystem levels.
| Effect Level | Main Mechanism Involved | Observed Outcomes | Type of Study/Model System Investigated |
|---|---|---|---|
| Epigenetic level | DNA methylation, histone modifications, and altered noncoding RNAs | Altered gene expression patterns, transgenerational inheritance of phenotypes | Mechanistic studies on rodent models |
| Neurodevelopmental level | Disruption of neural circuit formation, altered neurotransmitter systems, and hormone receptor modulation | Cognitive deficits, anxiety, and social behavior alterations | Mechanistic studies on rodent models; |
| Behavioral level (individual) | Neuroendocrine axis disruption (hypothalamic–pituitary–gonadal axis, hypothalamic–pituitary–adrenal axis), synaptic plasticity impairment | Anxiety, hyperactivity, altered sociability, attention deficits | Observational studies on human cohorts; mechanistic studies on rodent models |
| Behavioral level (population/ | Disrupted mating, social structures, predator-prey dynamics | Reduced fertility, altered colony stability, increased predation risk | Human observational (epidemiological); observational/speculative on various wildlife species |
| Ecosystem functions | Cumulative behavioral alterations in key species | Loss of ecosystem services (pollination, seed dispersal), and biodiversity decline | Observational/speculative/mechanistic studies on wildlife models |
1. Chormare, R.; Kumar, M.A. Environmental Health and Risk Assessment Metrics with Special Mention to Biotransfer, Bioaccumulation and Biomagnification of Environmental Pollutants. Chemosphere; 2022; 302, 134836. [DOI: https://dx.doi.org/10.1016/j.chemosphere.2022.134836]
2. Khan, S.; Naushad, M.; Govarthanan, M.; Iqbal, J.; Alfadul, S.M. Emerging Contaminants of High Concern for the Environment: Current Trends and Future Research. Environ. Res.; 2022; 207, 112609. [DOI: https://dx.doi.org/10.1016/j.envres.2021.112609]
3. Fortenberry, G.Z.; Meeker, J.D.; Sánchez, B.N.; Barr, D.B.; Panuwet, P.; Bellinger, D.; Schnaas, L.; Solano-González, M.; Ettinger, A.S.; Hernandez-Avila, M.
4. Maitre, L.; Robinson, O.; Martinez, D.; Toledano, M.B.; Ibarluzea, J.; Marina, L.S.; Sunyer, J.; Villanueva, C.M.; Keun, H.C.; Vrijheid, M.
5. Merrill, A.K.; Sobolewski, M.; Susiarjo, M. Exposure to Endocrine Disrupting Chemicals Impacts Immunological and Metabolic Status of Women during Pregnancy. Mol. Cell. Endocrinol.; 2023; 577, 112031. [DOI: https://dx.doi.org/10.1016/j.mce.2023.112031] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37506868]
6. Piazza, M.J.; Urbanetz, A.A. Environmental Toxins and the Impact of Other Endocrine Disrupting Chemicals in Women’s Reproductive Health. JBRA Assist. Reprod.; 2019; 23, pp. 154-164. [DOI: https://dx.doi.org/10.5935/1518-0557.20190016]
7. Rizzo, R.; Bortolotti, D.; Rizzo, S.; Schiuma, G. Endocrine Disruptors, Epigenetic Changes, and Transgenerational Transmission. Environment Impact on Reproductive Health: A Translational Approach; Marci, R. Springer International Publishing: Cham, Switzerland, 2023; pp. 49-74. ISBN 978-3-031-36494-5
8. WHO/IPCS. Global Assessment on the State of the Science of Endocrine Disruptors; WHO: Geneva, Switzerland, 2002; 180.
9. Demirtaş, İ.; Mızık, E.T.; Can-Güven, E.; Gedik, K. A Data-Driven Analysis of Global Research Trends on Dirty-Dozen Persistent Organic Pollutants. Environ. Monit. Assess.; 2023; 195, 1115. [DOI: https://dx.doi.org/10.1007/s10661-023-11722-8]
10. Guillotin, S.; Delcourt, N. Studying the Impact of Persistent Organic Pollutants Exposure on Human Health by Proteomic Analysis: A Systematic Review. Int. J. Mol. Sci.; 2022; 23, 14271. [DOI: https://dx.doi.org/10.3390/ijms232214271]
11. Grasselli, E.; Dvorakova, M.; Graceli, J.B. Editorial: Presence and Daily Exposure to Endocrine Disruptors: How Can Human Life Change?. Front. Endocrinol.; 2021; 12, 790853. [DOI: https://dx.doi.org/10.3389/fendo.2021.790853]
12. Kabir, E.R.; Rahman, M.S.; Rahman, I. A Review on Endocrine Disruptors and Their Possible Impacts on Human Health. Environ. Toxicol. Pharmacol.; 2015; 40, pp. 241-258. [DOI: https://dx.doi.org/10.1016/j.etap.2015.06.009]
13. Yilmaz, B.; Terekeci, H.; Sandal, S.; Kelestimur, F. Endocrine Disrupting Chemicals: Exposure, Effects on Human Health, Mechanism of Action, Models for Testing and Strategies for Prevention. Rev. Endocr. Metab. Disord.; 2020; 21, pp. 127-147. [DOI: https://dx.doi.org/10.1007/s11154-019-09521-z]
14. Masi, M.; Racchi, M.; Travelli, C.; Corsini, E.; Buoso, E. Molecular Characterization of Membrane Steroid Receptors in Hormone-Sensitive Cancers. Cells; 2021; 10, 2999. [DOI: https://dx.doi.org/10.3390/cells10112999] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34831222]
15. Chen, Y.; Lin, M.; Zhuang, D. Wastewater Treatment and Emerging Contaminants: Bibliometric Analysis. Chemosphere; 2022; 297, 133932. [DOI: https://dx.doi.org/10.1016/j.chemosphere.2022.133932] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35149018]
16. Kelley, A.S.; Banker, M.; Goodrich, J.M.; Dolinoy, D.C.; Burant, C.; Domino, S.E.; Smith, Y.R.; Song, P.X.K.; Padmanabhan, V. Early Pregnancy Exposure to Endocrine Disrupting Chemical Mixtures Are Associated with Inflammatory Changes in Maternal and Neonatal Circulation. Sci. Rep.; 2019; 9, 5422. [DOI: https://dx.doi.org/10.1038/s41598-019-41134-z] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30931951]
17. Rolfo, A.; Nuzzo, A.M.; De Amicis, R.; Moretti, L.; Bertoli, S.; Leone, A. Fetal–Maternal Exposure to Endocrine Disruptors: Correlation with Diet Intake and Pregnancy Outcomes. Nutrients; 2020; 12, 1744. [DOI: https://dx.doi.org/10.3390/nu12061744]
18. Street, M.E.; Bernasconi, S. Endocrine-Disrupting Chemicals in Human Fetal Growth. Int. J. Mol. Sci.; 2020; 21, 1430. [DOI: https://dx.doi.org/10.3390/ijms21041430]
19. Shekhar, S.; Sood, S.; Showkat, S.; Lite, C.; Chandrasekhar, A.; Vairamani, M.; Barathi, S.; Santosh, W. Detection of Phenolic Endocrine Disrupting Chemicals (EDCs) from Maternal Blood Plasma and Amniotic Fluid in Indian Population. Gen. Comp. Endocrinol.; 2017; 241, pp. 100-107. [DOI: https://dx.doi.org/10.1016/j.ygcen.2016.05.025]
20. Tang, Z.-R.; Xu, X.-L.; Deng, S.-L.; Lian, Z.-X.; Yu, K. Oestrogenic Endocrine Disruptors in the Placenta and the Fetus. Int. J. Mol. Sci.; 2020; 21, 1519. [DOI: https://dx.doi.org/10.3390/ijms21041519]
21. Svensson, K.; Gennings, C.; Lindh, C.; Kiviranta, H.; Rantakokko, P.; Wikström, S.; Bornehag, C.-G. Prenatal Exposures to Mixtures of Endocrine Disrupting Chemicals and Sex-Specific Associations with Children’s BMI and Overweight at 5.5 Years of Age in the SELMA Study. Environ. Int.; 2023; 179, 108176. [DOI: https://dx.doi.org/10.1016/j.envint.2023.108176]
22. Maddalon, A.; Cari, L.; Iulini, M.; Alhosseini, M.N.; Galbiati, V.; Marinovich, M.; Nocentini, G.; Corsini, E. Impact of Endocrine Disruptors on Peripheral Blood Mononuclear Cells in Vitro: Role of Gender. Arch. Toxicol.; 2023; 97, pp. 3129-3150. [DOI: https://dx.doi.org/10.1007/s00204-023-03592-3]
23. Maddalon, A.; Masi, M.; Iulini, M.; Linciano, P.; Galbiati, V.; Marinovich, M.; Racchi, M.; Buoso, E.; Corsini, E. Effects of Endocrine Active Contaminating Pesticides on RACK1 Expression and Immunological Consequences in THP-1 Cells. Environ. Toxicol. Pharmacol.; 2022; 95, 103971. [DOI: https://dx.doi.org/10.1016/j.etap.2022.103971]
24. Buoso, E.; Masi, M.; Racchi, M.; Corsini, E. Endocrine-Disrupting Chemicals’ (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1. Int. J. Mol. Sci.; 2020; 21, 9229. [DOI: https://dx.doi.org/10.3390/ijms21239229] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33287384]
25. Buoso, E.; Masi, M.; Long, A.; Chiappini, C.; Travelli, C.; Govoni, S.; Racchi, M. Ribosomes as a Nexus between Translation and Cancer Progression: Focus on Ribosomal Receptor for Activated C Kinase 1 (RACK1) in Breast Cancer. Br. J. Pharmacol.; 2022; 179, pp. 2813-2828. [DOI: https://dx.doi.org/10.1111/bph.15218] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32726469]
26. Arneth, B. Tumor Microenvironment. Medicina; 2019; 56, 15. [DOI: https://dx.doi.org/10.3390/medicina56010015]
27. Pivonello, C.; Muscogiuri, G.; Nardone, A.; Garifalos, F.; Provvisiero, D.P.; Verde, N.; de Angelis, C.; Conforti, A.; Piscopo, M.; Auriemma, R.S.
28. Brehm, E.; Flaws, J.A. Transgenerational Effects of Endocrine-Disrupting Chemicals on Male and Female Reproduction. Endocrinology; 2019; 160, pp. 1421-1435. [DOI: https://dx.doi.org/10.1210/en.2019-00034]
29. Siracusa, J.S.; Yin, L.; Measel, E.; Liang, S.; Yu, X. Effects of Bisphenol A and Its Analogs on Reproductive Health: A Mini Review. Reprod. Toxicol.; 2018; 79, pp. 96-123. [DOI: https://dx.doi.org/10.1016/j.reprotox.2018.06.005]
30. Wang, W.; Hafner, K.S.; Flaws, J.A. In Utero Bisphenol A Exposure Disrupts Germ Cell Nest Breakdown and Reduces Fertility with Age in the Mouse. Toxicol. Appl. Pharmacol.; 2014; 276, pp. 157-164. [DOI: https://dx.doi.org/10.1016/j.taap.2014.02.009]
31. Wisniewski, P.; Romano, R.M.; Kizys, M.M.L.; Oliveira, K.C.; Kasamatsu, T.; Giannocco, G.; Chiamolera, M.I.; Dias-da-Silva, M.R.; Romano, M.A. Adult Exposure to Bisphenol A (BPA) in Wistar Rats Reduces Sperm Quality with Disruption of the Hypothalamic–Pituitary–Testicular Axis. Toxicology; 2015; 329, pp. 1-9. [DOI: https://dx.doi.org/10.1016/j.tox.2015.01.002]
32. Heindel, J.J.; Blumberg, B.; Cave, M.; Machtinger, R.; Mantovani, A.; Mendez, M.A.; Nadal, A.; Palanza, P.; Panzica, G.; Sargis, R.
33. Aronica, L.; Ordovas, J.M.; Volkov, A.; Lamb, J.J.; Stone, P.M.; Minich, D.; Leary, M.; Class, M.; Metti, D.; Larson, I.A.
34. Bornman, M.; Delport, R.; Farías, P.; Aneck-Hahn, N.; Patrick, S.; Millar, R.P.; de Jager, C. Alterations in Male Reproductive Hormones in Relation to Environmental DDT Exposure. Environ. Int.; 2018; 113, pp. 281-289. [DOI: https://dx.doi.org/10.1016/j.envint.2017.12.039] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29373146]
35. Czarnywojtek, A.; Jaz, K.; Ochmańska, A.; Zgorzalewicz-Stachowiak, M.; Czarnocka, B.; Sawicka-Gutaj, N.; Ziółkowska, P.; Krela-Kaźmierczak, I.; Gut, P.; Florek, E.
36. Jarman, W.M.; Ballschmiter, K. From Coal to DDT: The History of the Development of the Pesticide DDT from Synthetic Dyes till Silent Spring. Endeavour; 2012; 36, pp. 131-142. [DOI: https://dx.doi.org/10.1016/j.endeavour.2012.10.003]
37. Jeng, H.A. Exposure to Endocrine Disrupting Chemicals and Male Reproductive Health. Front. Public Health; 2014; 2, 55. [DOI: https://dx.doi.org/10.3389/fpubh.2014.00055]
38. McCue, K.; DeNicola, N. Environmental Exposures in Reproductive Health. Obstet. Gynecol. Clin. N. Am.; 2019; 46, pp. 455-468. [DOI: https://dx.doi.org/10.1016/j.ogc.2019.04.005]
39. Braun, J.M. Early-Life Exposure to EDCs: Role in Childhood Obesity and Neurodevelopment. Nat. Rev. Endocrinol.; 2017; 13, pp. 161-173. [DOI: https://dx.doi.org/10.1038/nrendo.2016.186]
40. Rich, A.L.; Phipps, L.M.; Tiwari, S.; Rudraraju, H.; Dokpesi, P.O. The Increasing Prevalence in Intersex Variation from Toxicological Dysregulation in Fetal Reproductive Tissue Differentiation and Development by Endocrine-Disrupting Chemicals. Environ. Health Insights; 2016; 10, pp. 163-171. [DOI: https://dx.doi.org/10.4137/EHI.S39825]
41. Schwarzman, M. Potential Toxicity of Synthetic Chemicals: What You Should Know about Endocrine-Disrupting Chemicals. Am. Fam. Physician; 2008; 78, pp. 565-566.
42. Almstrup, K.; Frederiksen, H.; Andersson, A.-M.; Juul, A. Levels of Endocrine-Disrupting Chemicals Are Associated with Changes in the Peri-Pubertal Epigenome. Endocr. Connect.; 2020; 9, pp. 845-857. [DOI: https://dx.doi.org/10.1530/EC-20-0286]
43. Nettore, I.C.; Franchini, F.; Palatucci, G.; Macchia, P.E.; Ungaro, P. Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Obesity. Biomedicines; 2021; 9, 1716. [DOI: https://dx.doi.org/10.3390/biomedicines9111716]
44. Panera, N.; Mandato, C.; Crudele, A.; Bertrando, S.; Vajro, P.; Alisi, A. Genetics, Epigenetics and Transgenerational Transmission of Obesity in Children. Front. Endocrinol.; 2022; 13, 1006008. [DOI: https://dx.doi.org/10.3389/fendo.2022.1006008] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36452324]
45. Samtani, R.; Sharma, N.; Garg, D. Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review. Reprod. Sci.; 2018; 25, pp. 7-18. [DOI: https://dx.doi.org/10.1177/1933719117711261] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28602118]
46. Cediel-Ulloa, A.; Lupu, D.L.; Johansson, Y.; Hinojosa, M.; Özel, F.; Rüegg, J. Impact of Endocrine Disrupting Chemicals on Neurodevelopment: The Need for Better Testing Strategies for Endocrine Disruption-Induced Developmental Neurotoxicity. Expert. Rev. Endocrinol. Metab.; 2022; 17, pp. 131-141. [DOI: https://dx.doi.org/10.1080/17446651.2022.2044788]
47. Montero-Pedrazuela, A.; Grijota-Martínez, C.; Ausó, E.; Bárez-López, S.; Guadaño-Ferraz, A. Chapter 8—Endocrine Aspects of Development. Thyroid Hormone Actions in Neurological Processes during Brain Development. Diagnosis, Management and Modeling of Neurodevelopmental Disorders; Martin, C.R.; Preedy, V.R.; Rajendram, R. Academic Press: Cambridge, MA, USA, 2021; pp. 85-97. ISBN 978-0-12-817988-8
48. Makris, G.; Eleftheriades, A.; Pervanidou, P. Early Life Stress, Hormones, and Neurodevelopmental Disorders. Horm. Res. Paediatr.; 2023; 96, pp. 17-24. [DOI: https://dx.doi.org/10.1159/000523942] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35259742]
49. Anifantaki, F.; Pervanidou, P.; Lambrinoudaki, I.; Panoulis, K.; Vlahos, N.; Eleftheriades, M. Maternal Prenatal Stress, Thyroid Function and Neurodevelopment of the Offspring: A Mini Review of the Literature. Front. Neurosci.; 2021; 15, 692446. [DOI: https://dx.doi.org/10.3389/fnins.2021.692446]
50. Bludau, A.; Royer, M.; Meister, G.; Neumann, I.D.; Menon, R. Epigenetic Regulation of the Social Brain. Trends Neurosci.; 2019; 42, pp. 471-484. [DOI: https://dx.doi.org/10.1016/j.tins.2019.04.001]
51. Manley, K.; Han, W.; Zelin, G.; Lawrence, D.A. Crosstalk between the Immune, Endocrine, and Nervous Systems in Immunotoxicology. Curr. Opin. Toxicol.; 2018; 10, pp. 37-45. [DOI: https://dx.doi.org/10.1016/j.cotox.2017.12.003]
52. Wang, C.; He, T.; Qin, J.; Jiao, J.; Ji, F. The Roles of Immune Factors in Neurodevelopment. Front. Cell. Neurosci.; 2025; 19, 1451889. [DOI: https://dx.doi.org/10.3389/fncel.2025.1451889]
53. Kajta, M.; Wójtowicz, A.K. Impact of Endocrine-Disrupting Chemicals on Neural Development and the Onset of Neurological Disorders. Pharmacol. Rep.; 2013; 65, pp. 1632-1639. [DOI: https://dx.doi.org/10.1016/S1734-1140(13)71524-X]
54. Li, L.-X.; Chen, L.; Meng, X.-Z.; Chen, B.-H.; Chen, S.-Q.; Zhao, Y.; Zhao, L.-F.; Liang, Y.; Zhang, Y.-H. Exposure Levels of Environmental Endocrine Disruptors in Mother-Newborn Pairs in China and Their Placental Transfer Characteristics. PLoS ONE; 2013; 8, e62526. [DOI: https://dx.doi.org/10.1371/journal.pone.0062526] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23667484]
55. Pérez-Albaladejo, E.; Fernandes, D.; Lacorte, S.; Porte, C. Comparative Toxicity, Oxidative Stress and Endocrine Disruption Potential of Plasticizers in JEG-3 Human Placental Cells. Toxicol. Vitr.; 2017; 38, pp. 41-48. [DOI: https://dx.doi.org/10.1016/j.tiv.2016.11.003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27825933]
56. Roncati, L.; Piscioli, F.; Pusiol, T. The Endocrine Disruptors among the Environmental Risk Factors for Stillbirth. Sci. Total Environ.; 2016; 563–564, pp. 1086-1087. [DOI: https://dx.doi.org/10.1016/j.scitotenv.2016.04.214] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27216966]
57. Vizcaino, E.; Grimalt, J.O.; Fernández-Somoano, A.; Tardon, A. Transport of Persistent Organic Pollutants across the Human Placenta. Environ. Int.; 2014; 65, pp. 107-115. [DOI: https://dx.doi.org/10.1016/j.envint.2014.01.004]
58. Mao, J.; Jain, A.; Denslow, N.D.; Nouri, M.-Z.; Chen, S.; Wang, T.; Zhu, N.; Koh, J.; Sarma, S.J.; Sumner, B.W.
59. Forger, N.G. Cell Death and Sexual Differentiation of the Nervous System. Neuroscience; 2006; 138, pp. 929-938. [DOI: https://dx.doi.org/10.1016/j.neuroscience.2005.07.006]
60. McCarthy, M.M.; Auger, A.P.; Bale, T.L.; De Vries, G.J.; Dunn, G.A.; Forger, N.G.; Murray, E.K.; Nugent, B.M.; Schwarz, J.M.; Wilson, M.E. The Epigenetics of Sex Differences in the Brain. J. Neurosci.; 2009; 29, pp. 12815-12823. [DOI: https://dx.doi.org/10.1523/JNEUROSCI.3331-09.2009]
61. Schug, T.T.; Blawas, A.M.; Gray, K.; Heindel, J.J.; Lawler, C.P. Elucidating the Links between Endocrine Disruptors and Neurodevelopment. Endocrinology; 2015; 156, pp. 1941-1951. [DOI: https://dx.doi.org/10.1210/en.2014-1734]
62. Juricek, L.; Coumoul, X. The Aryl Hydrocarbon Receptor and the Nervous System. Int. J. Mol. Sci.; 2018; 19, 2504. [DOI: https://dx.doi.org/10.3390/ijms19092504]
63. Poland, A.; Glover, E.; Kende, A.S. Stereospecific, High Affinity Binding of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin by Hepatic Cytosol. Evidence That the Binding Species Is Receptor for Induction of Aryl Hydrocarbon Hydroxylase. J. Biol. Chem.; 1976; 251, pp. 4936-4946. [DOI: https://dx.doi.org/10.1016/S0021-9258(17)33205-2]
64. Bruner-Tran, K.L.; Gnecco, J.; Ding, T.; Glore, D.R.; Pensabene, V.; Osteen, K.G. Exposure to the Environmental Endocrine Disruptor TCDD and Human Reproductive Dysfunction: Translating Lessons from Murine Models. Reprod. Toxicol.; 2017; 68, pp. 59-71. [DOI: https://dx.doi.org/10.1016/j.reprotox.2016.07.007]
65. Martin, N.R.; Patel, R.; Kossack, M.E.; Tian, L.; Camarillo, M.A.; Cintrón-Rivera, L.G.; Gawdzik, J.C.; Yue, M.S.; Nwagugo, F.O.; Elemans, L.M.H.
66. Baraka, A.M.; Korish, A.A.; Soliman, G.A.; Kamal, H. The Possible Role of Estrogen and Selective Estrogen Receptor Modulators in a Rat Model of Parkinson’s Disease. Life Sci.; 2011; 88, pp. 879-885. [DOI: https://dx.doi.org/10.1016/j.lfs.2011.03.010] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21420980]
67. D’Astous, M.; Morissette, M.; Di Paolo, T. Effect of Estrogen Receptor Agonists Treatment in MPTP Mice: Evidence of Neuroprotection by an ERα Agonist. Neuropharmacology; 2004; 47, pp. 1180-1188. [DOI: https://dx.doi.org/10.1016/j.neuropharm.2004.08.020]
68. Salama, R.M.; Tadros, M.G.; Schaalan, M.F.; Bahaa, N.; Abdel-tawab, A.M.; Khalifa, A.E. Potential Neuroprotective Effect of Androst-5-ene-3β, 17β-diol (ADIOL) on the Striatum, and Substantia Nigra in Parkinson’s Disease Rat Model. J. Cell. Physiol.; 2018; 233, pp. 5981-6000. [DOI: https://dx.doi.org/10.1002/jcp.26412]
69. Zhao, L.; Mao, Z.; Chen, S.; Schneider, L.S.; Brinton, R.D. Early Intervention with an Estrogen Receptor β-Selective Phytoestrogenic Formulation Prolongs Survival, Improves Spatial Recognition Memory, and Slows Progression of Amyloid Pathology in a Female Mouse Model of Alzheimer’s Disease. J. Alzheimer’s Dis.; 2013; 37, pp. 403-419. [DOI: https://dx.doi.org/10.3233/JAD-122341]
70. Thambirajah, A.A.; Wade, M.G.; Verreault, J.; Buisine, N.; Alves, V.A.; Langlois, V.S.; Helbing, C.C. Disruption by Stealth—Interference of Endocrine Disrupting Chemicals on Hormonal Crosstalk with Thyroid Axis Function in Humans and Other Animals. Environ. Res.; 2022; 203, 111906. [DOI: https://dx.doi.org/10.1016/j.envres.2021.111906]
71. Allen, J.G.; Gale, S.; Zoeller, R.T.; Spengler, J.D.; Birnbaum, L.; McNeely, E. PBDE Flame Retardants, Thyroid Disease, and Menopausal Status in U.S. Women. Environ. Health; 2016; 15, 60. [DOI: https://dx.doi.org/10.1186/s12940-016-0141-0]
72. Blake, B.E.; Pinney, S.M.; Hines, E.P.; Fenton, S.E.; Ferguson, K.K. Associations between Longitudinal Serum Perfluoroalkyl Substance (PFAS) Levels and Measures of Thyroid Hormone, Kidney Function, and Body Mass Index in the Fernald Community Cohort. Environ. Pollut.; 2018; 242, pp. 894-904. [DOI: https://dx.doi.org/10.1016/j.envpol.2018.07.042]
73. Noda, M. Chapter Thirteen—Thyroid Hormone in the CNS: Contribution of Neuron–Glia Interaction. Vitamins and Hormones; Litwack, G. Thyroid Hormone Academic Press: New York, NY, USA, 2018; Volume 106, pp. 313-331.
74. Gould, E.; Butcher, L.L. Developing Cholinergic Basal Forebrain Neurons Are Sensitive to Thyroid Hormone. J. Neurosci.; 1989; 9, pp. 3347-3358. [DOI: https://dx.doi.org/10.1523/JNEUROSCI.09-09-03347.1989]
75. Gould, E.; Frankfurt, M.; Westlind-Danielsson, A.; McEwen, B.S. Developing Forebrain Astrocytes Are Sensitive to Thyroid Hormone. Glia; 1990; 3, pp. 283-292. [DOI: https://dx.doi.org/10.1002/glia.440030408]
76. Lima, F.R.; Gervais, A.; Colin, C.; Izembart, M.; Neto, V.M.; Mallat, M. Regulation of Microglial Development: A Novel Role for Thyroid Hormone. J. Neurosci.; 2001; 21, pp. 2028-2038. [DOI: https://dx.doi.org/10.1523/JNEUROSCI.21-06-02028.2001]
77. Rodriguez-Peña, A.; Ibarrola, N.; Iñiguez, M.A.; Muñoz, A.; Bernal, J. Neonatal Hypothyroidism Affects the Timely Expression of Myelin-Associated Glycoprotein in the Rat Brain. J. Clin. Investig.; 1993; 91, pp. 812-818. [DOI: https://dx.doi.org/10.1172/JCI116301] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/7680668]
78. Ge, G.M.; Leung, M.T.Y.; Man, K.K.C.; Leung, W.C.; Ip, P.; Li, G.H.Y.; Wong, I.C.K.; Kung, A.W.C.; Cheung, C.-L. Maternal Thyroid Dysfunction During Pregnancy and the Risk of Adverse Outcomes in the Offspring: A Systematic Review and Meta-Analysis. J. Clin. Endocrinol. Metab.; 2020; 105, pp. 3821-3841. [DOI: https://dx.doi.org/10.1210/clinem/dgaa555] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32810262]
79. Román, G.C.; Ghassabian, A.; Bongers-Schokking, J.J.; Jaddoe, V.W.V.; Hofman, A.; De Rijke, Y.B.; Verhulst, F.C.; Tiemeier, H. Association of Gestational Maternal Hypothyroxinemia and Increased Autism Risk. Ann. Neurol.; 2013; 74, pp. 733-742. [DOI: https://dx.doi.org/10.1002/ana.23976] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23943579]
80. Chen, Z.-P.; Hetzel, B.S. Cretinism Revisited. Best. Pract. Res. Clin. Endocrinol. Metab.; 2010; 24, pp. 39-50. [DOI: https://dx.doi.org/10.1016/j.beem.2009.08.014]
81. Meerts, I.A.T.M.; Lilienthal, H.; Hoving, S.; van den Berg, J.H.J.; Weijers, B.M.; Bergman, Å.; Koeman, J.H.; Brouwer, A. Developmental Exposure to 4-Hydroxy-2,3,3′,4′,5-Pentachlorobiphenyl (4-OH-CB107): Long-Term Effects on Brain Development, Behavior, and Brain Stem Auditory Evoked Potentials in Rats. Toxicol. Sci.; 2004; 82, pp. 207-218. [DOI: https://dx.doi.org/10.1093/toxsci/kfh252]
82. Babić Leko, M.; Pleić, N.; Lešin, M.; Gunjača, I.; Torlak, V.; Škunca Herman, J.; Vatavuk, Z.; Punda, A.; Polašek, O.; Hayward, C.
83. Pontelli, R.C.N.; Souza, M.C.O.; Fantucci, M.Z.; de Andrade, M.; Rocha, E.M. The Role of Endocrine Disruptors in Ocular Surface Diseases. Med. Hypotheses; 2019; 122, pp. 157-164. [DOI: https://dx.doi.org/10.1016/j.mehy.2018.11.009]
84. Yang, F.; Ma, H.; Ding, X.-Q. Thyroid Hormone Signaling in Retinal Development, Survival, and Disease. Vitam. Horm.; 2018; 106, pp. 333-349. [DOI: https://dx.doi.org/10.1016/bs.vh.2017.05.001]
85. Chen, Z.-F.; Lin, Z.-C.; Lu, S.-Q.; Chen, X.-F.; Liao, X.-L.; Qi, Z.; Cai, Z. Azole-Induced Color Vision Deficiency Associated with Thyroid Hormone Signaling: An Integrated In Vivo, In Vitro, and In Silico Study. Environ. Sci. Technol.; 2022; 56, pp. 13264-13273. [DOI: https://dx.doi.org/10.1021/acs.est.2c05328]
86. Jiang, Y.; Zhang, S.; Zhang, X.; Li, N.; Zhang, Q.; Guo, X.; Chi, X.; Tong, M. Peptidomic Analysis of Zebrafish Embryos Exposed to Polychlorinated Biphenyls and Their Impact on Eye Development. Ecotoxicol. Environ. Saf.; 2019; 175, pp. 164-172. [DOI: https://dx.doi.org/10.1016/j.ecoenv.2019.03.015] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30897415]
87. Kilburn, K.H. Visual and Neurobehavioral Impairment Associated with Polychlorinated Biphenyls. Neurotoxicology; 2000; 21, pp. 489-499. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11022858]
88. Wang, Y.-P.; Hong, Q.; Qin, D.; Kou, C.-Z.; Zhang, C.-M.; Guo, M.; Guo, X.-R.; Chi, X.; Tong, M.-L. Effects of Embryonic Exposure to Polychlorinated Biphenyls on Zebrafish (Danio Rerio) Retinal Development. J. Appl. Toxicol.; 2012; 32, pp. 186-193. [DOI: https://dx.doi.org/10.1002/jat.1650] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21381056]
89. Baumann, L.; Segner, H.; Ros, A.; Knapen, D.; Vergauwen, L. Thyroid Hormone Disruptors Interfere with Molecular Pathways of Eye Development and Function in Zebrafish. Int. J. Mol. Sci.; 2019; 20, 1543. [DOI: https://dx.doi.org/10.3390/ijms20071543]
90. Hasegawa, M.; Wada, H. Developmental Hypothyroidism Disrupts Visual Signal Detection Performance in Rats. Physiol. Behav.; 2013; 112–113, pp. 90-95. [DOI: https://dx.doi.org/10.1016/j.physbeh.2013.02.019]
91. Knudsen, E.I. Evolution of Neural Processing for Visual Perception in Vertebrates. J. Comp. Neurol.; 2020; 528, pp. 2888-2901. [DOI: https://dx.doi.org/10.1002/cne.24871]
92. Zoeller, R.T.; Bansal, R.; Parris, C. Bisphenol-A, an Environmental Contaminant That Acts as a Thyroid Hormone Receptor Antagonist in Vitro, Increases Serum Thyroxine, and Alters RC3/Neurogranin Expression in the Developing Rat Brain. Endocrinology; 2005; 146, pp. 607-612. [DOI: https://dx.doi.org/10.1210/en.2004-1018]
93. Xiang, Y.; Xin, J.; Le, W.; Yang, Y. Neurogranin: A Potential Biomarker of Neurological and Mental Diseases. Front. Aging Neurosci.; 2020; 12, 584743. [DOI: https://dx.doi.org/10.3389/fnagi.2020.584743]
94. Diotel, N.; Charlier, T.D.; Lefebvre d’Hellencourt, C.; Couret, D.; Trudeau, V.L.; Nicolau, J.C.; Meilhac, O.; Kah, O.; Pellegrini, E. Steroid Transport, Local Synthesis, and Signaling within the Brain: Roles in Neurogenesis, Neuroprotection, and Sexual Behaviors. Front. Neurosci.; 2018; 12, 84. [DOI: https://dx.doi.org/10.3389/fnins.2018.00084]
95. Blanc-Legendre, M.; Sire, S.; Christophe, A.; Brion, F.; Bégout, M.-L.; Cousin, X. Embryonic Exposures to Chemicals Acting on Brain Aromatase Lead to Different Locomotor Effects in Zebrafish Larvae. Environ. Toxicol. Pharmacol.; 2023; 102, 104221. [DOI: https://dx.doi.org/10.1016/j.etap.2023.104221]
96. Bortolato, M.; Godar, S.C.; Davarian, S.; Chen, K.; Shih, J.C. Behavioral Disinhibition and Reduced Anxiety-like Behaviors in Monoamine Oxidase B-Deficient Mice. Neuropsychopharmacology; 2009; 34, pp. 2746-2757. [DOI: https://dx.doi.org/10.1038/npp.2009.118] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19710633]
97. Bortolato, M.; Shih, J.C. Behavioral Outcomes of Monoamine Oxidase Deficiency: Preclinical and Clinical Evidence. International Review of Neurobiology; Youdim, M.B.H.; Douce, P. Monoamine Oxidase and their Inhibitors Academic Press: Cambridge, MA, USA, 2011; Volume 100, pp. 13-42.
98. Matsuda, S.; Matsuzawa, D.; Ishii, D.; Tomizawa, H.; Sutoh, C.; Nakazawa, K.; Amano, K.; Sajiki, J.; Shimizu, E. Effects of Perinatal Exposure to Low Dose of Bisphenol A on Anxiety like Behavior and Dopamine Metabolites in Brain. Prog. Neuropsychopharmacol. Biol. Psychiatry; 2012; 39, pp. 273-279. [DOI: https://dx.doi.org/10.1016/j.pnpbp.2012.06.016] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22760093]
99. McRobb, F.M.; Sahagún, V.; Kufareva, I.; Abagyan, R. In Silico Analysis of the Conservation of Human Toxicity and Endocrine Disruption Targets in Aquatic Species. Environ. Sci. Technol.; 2014; 48, pp. 1964-1972. [DOI: https://dx.doi.org/10.1021/es404568a] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24392850]
100. Zhang, Z.; Chen, K.; Shih, J.C.; Teng, C.T. Estrogen-Related Receptors-Stimulated Monoamine Oxidase B Promoter Activity Is Down-Regulated by Estrogen Receptors. Mol. Endocrinol.; 2006; 20, pp. 1547-1561. [DOI: https://dx.doi.org/10.1210/me.2005-0252]
101. Dutta, H.M.; Arends, D.A. Effects of Endosulfan on Brain Acetylcholinesterase Activity in Juvenile Bluegill Sunfish. Environ. Res.; 2003; 91, pp. 157-162. [DOI: https://dx.doi.org/10.1016/S0013-9351(02)00062-2]
102. Diamanti-Kandarakis, E.; Bourguignon, J.-P.; Giudice, L.C.; Hauser, R.; Prins, G.S.; Soto, A.M.; Zoeller, R.T.; Gore, A.C. Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement. Endocr. Rev.; 2009; 30, pp. 293-342. [DOI: https://dx.doi.org/10.1210/er.2009-0002]
103. Kutsuno, Y.; Hirashima, R.; Sakamoto, M.; Ushikubo, H.; Michimae, H.; Itoh, T.; Tukey, R.H.; Fujiwara, R. Expression of UDP-Glucuronosyltransferase 1 (UGT1) and Glucuronidation Activity toward Endogenous Substances in Humanized UGT1 Mouse Brain. Drug Metab. Dispos.; 2015; 43, 1071. [DOI: https://dx.doi.org/10.1124/dmd.115.063719]
104. Ouzzine, M.; Gulberti, S.; Ramalanjaona, N.; Magdalou, J.; Fournel-Gigleux, S. The UDP-Glucuronosyltransferases of the Blood-Brain Barrier: Their Role in Drug Metabolism and Detoxication. Front. Cell. Neurosci.; 2014; 8, 349. [DOI: https://dx.doi.org/10.3389/fncel.2014.00349]
105. Sheng, Y.; Yang, H.; Wu, T.; Zhu, L.; Liu, L.; Liu, X. Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances. Front. Pharmacol.; 2021; 12, 650027. [DOI: https://dx.doi.org/10.3389/fphar.2021.650027]
106. Arambula, S.E.; McCarthy, M.M. Neuroendocrine-Immune Crosstalk Shapes Sex-Specific Brain Development. Endocrinology; 2020; 161, bqaa055. [DOI: https://dx.doi.org/10.1210/endocr/bqaa055]
107. Blalock, J.E. A Molecular Basis for Bidirectional Communication between the Immune and Neuroendocrine Systems. Physiol. Rev.; 1989; 69, pp. 1-32. [DOI: https://dx.doi.org/10.1152/physrev.1989.69.1.1] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/2536183]
108. Buoso, E.; Masi, M.; Limosani, R.V.; Oliviero, C.; Saeed, S.; Iulini, M.; Passoni, F.C.; Racchi, M.; Corsini, E. Endocrine Disrupting Toxicity of Bisphenol A and Its Analogs: Implications in the Neuro-Immune Milieu. J. Xenobiotics; 2025; 15, 13. [DOI: https://dx.doi.org/10.3390/jox15010013] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/39846545]
109. Reddy, V.; McCarthy, M.; Raval, A.P. Xenoestrogens Impact Brain Estrogen Receptor Signaling during the Female Lifespan: A Precursor to Neurological Disease?. Neurobiol. Dis.; 2022; 163, 105596. [DOI: https://dx.doi.org/10.1016/j.nbd.2021.105596] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34942334]
110. He, D.-Y.; Neasta, J.; Ron, D. Epigenetic Regulation of BDNF Expression via the Scaffolding Protein RACK1. J. Biol. Chem.; 2010; 285, pp. 19043-19050. [DOI: https://dx.doi.org/10.1074/jbc.M110.100693]
111. Cirillo, F.; Lappano, R.; Bruno, L.; Rizzuti, B.; Grande, F.; Guzzi, R.; Briguori, S.; Miglietta, A.M.; Nakajima, M.; Di Martino, M.T.
112. Yan, S.; Ji, J.; Zhang, Z.; Imam, M.; Chen, H.; Zhang, D.; Wang, J. Targeting the Crosstalk between Estrogen Receptors and Membrane Growth Factor Receptors in Breast Cancer Treatment: Advances and Opportunities. Biomed. Pharmacother.; 2024; 175, 116615. [DOI: https://dx.doi.org/10.1016/j.biopha.2024.116615]
113. Masi, M.; Maddalon, A.; Iulini, M.; Linciano, P.; Galbiati, V.; Marinovich, M.; Racchi, M.; Corsini, E.; Buoso, E. Effects of Endocrine Disrupting Chemicals on the Expression of RACK1 and LPS-Induced THP-1 Cell Activation. Toxicology; 2022; 480, 153321. [DOI: https://dx.doi.org/10.1016/j.tox.2022.153321]
114. Żabińska, M.; Wiśniewska, K.; Węgrzyn, G.; Pierzynowska, K. Exploring the Physiological Role of the G Protein-Coupled Estrogen Receptor (GPER) and Its Associations with Human Diseases. Psychoneuroendocrinology; 2024; 166, 107070. [DOI: https://dx.doi.org/10.1016/j.psyneuen.2024.107070]
115. Zheng, Y.; Wu, M.; Gao, T.; Meng, L.; Ding, X.; Meng, Y.; Jiao, Y.; Luo, P.; He, Z.; Sun, T.
116. Buoso, E.; Kenda, M.; Masi, M.; Linciano, P.; Galbiati, V.; Racchi, M.; Dolenc, M.S.; Corsini, E. Effects of Bisphenols on RACK1 Expression and Their Immunological Implications in THP-1 Cells. Front. Pharmacol.; 2021; 12, 743991. [DOI: https://dx.doi.org/10.3389/fphar.2021.743991]
117. Oudart, M.; Avila-Gutierrez, K.; Moch, C.; Dossi, E.; Milior, G.; Boulay, A.-C.; Gaudey, M.; Moulard, J.; Lombard, B.; Loew, D.
118. Takahashi, M.; Komada, M.; Miyazawa, K.; Goto, S.; Ikeda, Y. Bisphenol A Exposure Induces Increased Microglia and Microglial Related Factors in the Murine Embryonic Dorsal Telencephalon and Hypothalamus. Toxicol. Lett.; 2018; 284, pp. 113-119. [DOI: https://dx.doi.org/10.1016/j.toxlet.2017.12.010] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29248573]
119. Brandl, S.; Reindl, M. Blood–Brain Barrier Breakdown in Neuroinflammation: Current In Vitro Models. Int. J. Mol. Sci.; 2023; 24, 12699. [DOI: https://dx.doi.org/10.3390/ijms241612699] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37628879]
120. Ahmadpour, D.; Mhaouty-Kodja, S.; Grange-Messent, V. Disruption of the Blood-Brain Barrier and Its Close Environment Following Adult Exposure to Low Doses of Di(2-Ethylhexyl)Phthalate Alone or in an Environmental Phthalate Mixture in Male Mice. Chemosphere; 2021; 282, 131013. [DOI: https://dx.doi.org/10.1016/j.chemosphere.2021.131013] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34090004]
121. Alavian-Ghavanini, A.; Rüegg, J. Understanding Epigenetic Effects of Endocrine Disrupting Chemicals: From Mechanisms to Novel Test Methods. Basic Clin. Pharmacol. Toxicol.; 2018; 122, pp. 38-45. [DOI: https://dx.doi.org/10.1111/bcpt.12878]
122. Rattan, S.; Flaws, J.A. The Epigenetic Impacts of Endocrine Disruptors on Female Reproduction across Generations. Biol. Reprod.; 2019; 101, pp. 635-644. [DOI: https://dx.doi.org/10.1093/biolre/ioz081]
123. Singleton, D.W.; Feng, Y.; Yang, J.; Puga, A.; Lee, A.V.; Khan, S.A. Gene Expression Profiling Reveals Novel Regulation by Bisphenol-A in Estrogen Receptor-Alpha-Positive Human Cells. Environ. Res.; 2006; 100, pp. 86-92. [DOI: https://dx.doi.org/10.1016/j.envres.2005.05.004]
124. Walker, D.M.; Gore, A.C. Epigenetic Impacts of Endocrine Disruptors in the Brain. Front. Neuroendocrinol.; 2017; 44, pp. 1-26. [DOI: https://dx.doi.org/10.1016/j.yfrne.2016.09.002]
125. Sheng, J.A.; Bales, N.J.; Myers, S.A.; Bautista, A.I.; Roueinfar, M.; Hale, T.M.; Handa, R.J. The Hypothalamic-Pituitary-Adrenal Axis: Development, Programming Actions of Hormones, and Maternal-Fetal Interactions. Front. Behav. Neurosci.; 2021; 14, 601939. [DOI: https://dx.doi.org/10.3389/fnbeh.2020.601939]
126. Coussons-Read, M.E. Effects of Prenatal Stress on Pregnancy and Human Development: Mechanisms and Pathways. Obstet. Med.; 2013; 6, pp. 52-57. [DOI: https://dx.doi.org/10.1177/1753495x12473751]
127. Lazinski, M.J.; Shea, A.K.; Steiner, M. Effects of Maternal Prenatal Stress on Offspring Development: A Commentary. Arch. Womens Ment. Health; 2008; 11, pp. 363-375. [DOI: https://dx.doi.org/10.1007/s00737-008-0035-4]
128. Lund, I.O.; Hannigan, L.J.; Ask, H.; Askelund, A.D.; Hegemann, L.; Corfield, E.C.; Wootton, R.E.; Ahmadzadeh, Y.I.; Davey Smith, G.; McAdams, T.A.
129. LeWinn, K.Z.; Stroud, L.R.; Molnar, B.E.; Ware, J.H.; Koenen, K.C.; Buka, S.L. Elevated Maternal Cortisol Levels during Pregnancy Are Associated with Reduced Childhood IQ. Int. J. Epidemiol.; 2009; 38, pp. 1700-1710. [DOI: https://dx.doi.org/10.1093/ije/dyp200] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19423658]
130. Davis, E.P.; Sandman, C.A. Prenatal Psychobiological Predictors of Anxiety Risk in Preadolescent Children. Psychoneuroendocrinology; 2012; 37, pp. 1224-1233. [DOI: https://dx.doi.org/10.1016/j.psyneuen.2011.12.016]
131. Ronald, A.; Pennell, C.E.; Whitehouse, A.J.O. Prenatal Maternal Stress Associated with ADHD and Autistic Traits in Early Childhood. Front. Psychology; 2011; 1, 223. [DOI: https://dx.doi.org/10.3389/fpsyg.2010.00223]
132. Grundwald, N.J.; Brunton, P.J. Prenatal Stress Programs Neuroendocrine Stress Responses and Affective Behaviors in Second Generation Rats in a Sex-Dependent Manner. Psychoneuroendocrinology; 2015; 62, pp. 204-216. [DOI: https://dx.doi.org/10.1016/j.psyneuen.2015.08.010]
133. Short, A.K.; Fennell, K.A.; Perreau, V.M.; Fox, A.; O’Bryan, M.K.; Kim, J.H.; Bredy, T.W.; Pang, T.Y.; Hannan, A.J. Elevated Paternal Glucocorticoid Exposure Alters the Small Noncoding RNA Profile in Sperm and Modifies Anxiety and Depressive Phenotypes in the Offspring. Transl. Psychiatry; 2016; 6, e837. [DOI: https://dx.doi.org/10.1038/tp.2016.109]
134. Yeshurun, S.; Rogers, J.; Short, A.K.; Renoir, T.; Pang, T.Y.; Hannan, A.J. Elevated Paternal Glucocorticoid Exposure Modifies Memory Retention in Female Offspring. Psychoneuroendocrinology; 2017; 83, pp. 9-18. [DOI: https://dx.doi.org/10.1016/j.psyneuen.2017.05.014]
135. Di Criscio, M.; Lodahl, J.E.; Stamatakis, A.; Kitraki, E.; Bakoyiannis, I.; Repouskou, A.; Bornehag, C.-G.; Gennings, C.; Lupu, D.; Rüegg, J. A Human-Relevant Mixture of Endocrine Disrupting Chemicals Induces Changes in Hippocampal DNA Methylation Correlating with Hyperactive Behavior in Male Mice. Chemosphere; 2023; 313, 137633. [DOI: https://dx.doi.org/10.1016/j.chemosphere.2022.137633]
136. Yeo, M.; Berglund, K.; Hanna, M.; Guo, J.U.; Kittur, J.; Torres, M.D.; Abramowitz, J.; Busciglio, J.; Gao, Y.; Birnbaumer, L.
137. Yaoi, T.; Itoh, K.; Nakamura, K.; Ogi, H.; Fujiwara, Y.; Fushiki, S. Genome-Wide Analysis of Epigenomic Alterations in Fetal Mouse Forebrain after Exposure to Low Doses of Bisphenol A. Biochem. Biophys. Res. Commun.; 2008; 376, pp. 563-567. [DOI: https://dx.doi.org/10.1016/j.bbrc.2008.09.028]
138. Zhou, R.; Chen, F.; Chang, F.; Bai, Y.; Chen, L. Persistent Overexpression of DNA Methyltransferase 1 Attenuating GABAergic Inhibition in Basolateral Amygdala Accounts for Anxiety in Rat Offspring Exposed Perinatally to Low-Dose Bisphenol A. J. Psychiatr. Res.; 2013; 47, pp. 1535-1544. [DOI: https://dx.doi.org/10.1016/j.jpsychires.2013.05.013] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23791455]
139. Dickerson, S.M.; Cunningham, S.L.; Gore, A.C. Prenatal PCBs Disrupt Early Neuroendocrine Development of the Rat Hypothalamus. Toxicol. Appl. Pharmacol.; 2011; 252, pp. 36-46. [DOI: https://dx.doi.org/10.1016/j.taap.2011.01.012] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21277884]
140. Topper, V.Y.; Walker, D.M.; Gore, A.C. Sexually Dimorphic Effects of Gestational Endocrine-Disrupting Chemicals on MicroRNA Expression in the Developing Rat Hypothalamus. Mol. Cell. Endocrinol.; 2015; 414, 42. [DOI: https://dx.doi.org/10.1016/j.mce.2015.07.013] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26190835]
141. Ejaredar, M.; Nyanza, E.C.; Ten Eycke, K.; Dewey, D. Phthalate Exposure and Childrens Neurodevelopment: A Systematic Review. Environ. Res.; 2015; 142, pp. 51-60. [DOI: https://dx.doi.org/10.1016/j.envres.2015.06.014]
142. Luu, B.E.; Green, S.R.; Childers, C.L.; Holahan, M.R.; Storey, K.B. The Roles of Hippocampal microRNAs in Response to Acute Postnatal Exposure to Di(2-Ethylhexyl) Phthalate in Female and Male Rats. NeuroToxicology; 2017; 59, pp. 98-104. [DOI: https://dx.doi.org/10.1016/j.neuro.2017.02.004]
143. Qiu, F.; He, S.; Zhang, Z.; Dai, S.; Wang, J.; Liu, N.; Li, Z.; Hu, X.; Xiang, S.; Wei, C. MiR-93 Alleviates DEHP Plasticizer-Induced Neurotoxicity by Negatively Regulating TNFAIP1 and Inhibiting Ubiquitin-Mediated Degradation of CK2β. Food Chem. Toxicol.; 2023; 178, 113888. [DOI: https://dx.doi.org/10.1016/j.fct.2023.113888]
144. Hung, C.-H.; Yang, S.-N.; Kuo, P.-L.; Chu, Y.-T.; Chang, H.-W.; Wei, W.-J.; Huang, S.-K.; Jong, Y.-J. Modulation of Cytokine Expression in Human Myeloid Dendritic Cells by Environmental Endocrine-Disrupting Chemicals Involves Epigenetic Regulation. Environ. Health Perspect.; 2010; 118, pp. 67-72. [DOI: https://dx.doi.org/10.1289/ehp.0901011]
145. Yeh, C.-H.; Wu, H.-C.; Kuo, T.-H.; Kuo, C.-H.; Yang, S.-N.; Wang, W.-L.; Chen, H.-N.; Wei, W.-J.; Hung, C.-H. Suppressive Effect on MDC and IP-10 Expression in Monocytes by Endocrine Disruptor Chemicals. Inflammation; 2010; 33, pp. 10-17. [DOI: https://dx.doi.org/10.1007/s10753-009-9153-z]
146. O’Brien, E.; Dolinoy, D.C.; Mancuso, P. Perinatal Bisphenol A Exposures Increase Production of Pro-Inflammatory Mediators in Bone Marrow-Derived Mast Cells of Adult Mice. J. Immunotoxicol.; 2014; 11, pp. 205-212. [DOI: https://dx.doi.org/10.3109/1547691X.2013.822036]
147. Calero-Medina, L.; Jimenez-Casquet, M.J.; Heras-Gonzalez, L.; Conde-Pipo, J.; Lopez-Moro, A.; Olea-Serrano, F.; Mariscal-Arcas, M. Dietary Exposure to Endocrine Disruptors in Gut Microbiota: A Systematic Review. Sci. Total Environ.; 2023; 886, 163991. [DOI: https://dx.doi.org/10.1016/j.scitotenv.2023.163991]
148. Hampl, R.; Stárka, L. Endocrine Disruptors and Gut Microbiome Interactions. Physiol. Res.; 2020; 69, pp. S211-S223. [DOI: https://dx.doi.org/10.33549/physiolres.934513]
149. Shemtov, S.J.; Emani, R.; Bielska, O.; Covarrubias, A.J.; Verdin, E.; Andersen, J.K.; Winer, D.A. The Intestinal Immune System and Gut Barrier Function in Obesity and Ageing. FEBS J.; 2023; 290, pp. 4163-4186. [DOI: https://dx.doi.org/10.1111/febs.16558] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35727858]
150. Buoso, E.; Galasso, M.; Ronfani, M.; Papale, A.; Galbiati, V.; Eberini, I.; Marinovich, M.; Racchi, M.; Corsini, E. The Scaffold Protein RACK1 Is a Target of Endocrine Disrupting Chemicals (EDCs) with Important Implication in Immunity. Toxicol. Appl. Pharmacol.; 2017; 325, pp. 37-47. [DOI: https://dx.doi.org/10.1016/j.taap.2017.04.011] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28412309]
151. Buoso, E.; Masi, M.; Galbiati, V.; Maddalon, A.; Iulini, M.; Kenda, M.; Sollner Dolenc, M.; Marinovich, M.; Racchi, M.; Corsini, E. Effect of Estrogen-Active Compounds on the Expression of RACK1 and Immunological Implications. Arch. Toxicol.; 2020; 94, pp. 2081-2095. [DOI: https://dx.doi.org/10.1007/s00204-020-02756-9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32328699]
152. Pahović, P.Š.; Iulini, M.; Maddalon, A.; Galbiati, V.; Buoso, E.; Dolenc, M.S.; Corsini, E. In Vitro Effects of Bisphenol Analogs on Immune Cells Activation and Th Differentiation. Endocr. Metab. Immune Disord. Drug Targets; 2023; 23, pp. 1750-1761. [DOI: https://dx.doi.org/10.2174/1871530323666230216150614]
153. O’Brien, E.; Dolinoy, D.C.; Mancuso, P. Bisphenol A at Concentrations Relevant to Human Exposure Enhances Histamine and Cysteinyl Leukotriene Release from Bone Marrow-Derived Mast Cells. J. Immunotoxicol.; 2014; 11, pp. 84-89. [DOI: https://dx.doi.org/10.3109/1547691X.2013.800925]
154. Ménard, S.; Guzylack-Piriou, L.; Lencina, C.; Leveque, M.; Naturel, M.; Sekkal, S.; Harkat, C.; Gaultier, E.; Olier, M.; Garcia-Villar, R.
155. Clemente-Suárez, V.J.; Redondo-Flórez, L.; Rubio-Zarapuz, A.; Martín-Rodríguez, A.; Tornero-Aguilera, J.F. Microbiota Implications in Endocrine-Related Diseases: From Development to Novel Therapeutic Approaches. Biomedicines; 2024; 12, 221. [DOI: https://dx.doi.org/10.3390/biomedicines12010221]
156. Kandpal, M.; Indari, O.; Baral, B.; Jakhmola, S.; Tiwari, D.; Bhandari, V.; Pandey, R.K.; Bala, K.; Sonawane, A.; Jha, H.C. Dysbiosis of Gut Microbiota from the Perspective of the Gut–Brain Axis: Role in the Provocation of Neurological Disorders. Metabolites; 2022; 12, 1064. [DOI: https://dx.doi.org/10.3390/metabo12111064]
157. Appleton, J. The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health. Integr. Med.; 2018; 17, pp. 28-32.
158. Kumar, A.; Pramanik, J.; Goyal, N.; Chauhan, D.; Sivamaruthi, B.S.; Prajapati, B.G.; Chaiyasut, C. Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options. Pharmaceuticals; 2023; 16, 565. [DOI: https://dx.doi.org/10.3390/ph16040565]
159. Caspani, G.; Swann, J. Small Talk: Microbial Metabolites Involved in the Signaling from Microbiota to Brain. Curr. Opin. Pharmacol.; 2019; 48, pp. 99-106. [DOI: https://dx.doi.org/10.1016/j.coph.2019.08.001]
160. Al-Asmakh, M.; Anuar, F.; Zadjali, F.; Rafter, J.; Pettersson, S. Gut Microbial Communities Modulating Brain Development and Function. Gut Microbes; 2012; 3, pp. 366-373. [DOI: https://dx.doi.org/10.4161/gmic.21287]
161. Fellows, R.; Denizot, J.; Stellato, C.; Cuomo, A.; Jain, P.; Stoyanova, E.; Balázsi, S.; Hajnády, Z.; Liebert, A.; Kazakevych, J.
162. Li, L.; Zhao, S.; Xiang, T.; Feng, H.; Ma, L.; Fu, P. Epigenetic Connection between Gut Microbiota-Derived Short-Chain Fatty Acids and Chromatin Histone Modification in Kidney Diseases. Chin. Med. J.; 2022; 135, pp. 1692-1694. [DOI: https://dx.doi.org/10.1097/CM9.0000000000002295] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36193977]
163. Stein, R.A.; Riber, L. Epigenetic Effects of Short-Chain Fatty Acids from the Large Intestine on Host Cells. Microlife; 2023; 4, uqad032. [DOI: https://dx.doi.org/10.1093/femsml/uqad032] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37441522]
164. Xie, A.; Ensink, E.; Li, P.; Gordevičius, J.; Marshall, L.L.; George, S.; Pospisilik, J.A.; Aho, V.T.E.; Houser, M.C.; Pereira, P.A.B.
165. Reva, K.; Laranjinha, J.; Rocha, B.S. Epigenetic Modifications Induced by the Gut Microbiota May Result from What We Eat: Should We Talk about Precision Diet in Health and Disease?. Metabolites; 2023; 13, 375. [DOI: https://dx.doi.org/10.3390/metabo13030375]
166. Romano, K.A.; Martinez-Del Campo, A.; Kasahara, K.; Chittim, C.L.; Vivas, E.I.; Amador-Noguez, D.; Balskus, E.P.; Rey, F.E. Metabolic, Epigenetic, and Transgenerational Effects of Gut Bacterial Choline Consumption. Cell Host Microbe; 2017; 22, pp. 279-290.e7. [DOI: https://dx.doi.org/10.1016/j.chom.2017.07.021]
167. Mellott, T.J.; Kowall, N.W.; Lopez-Coviella, I.; Blusztajn, J.K. Prenatal Choline Deficiency Increases Choline Transporter Expression in the Septum and Hippocampus during Postnatal Development and in Adulthood in Rats. Brain Res.; 2007; 1151, pp. 1-11. [DOI: https://dx.doi.org/10.1016/j.brainres.2007.03.004] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17399691]
168. Zeisel, S.H. Gene Response Elements, Genetic Polymorphisms and Epigenetics Influence the Human Dietary Requirement for Choline. IUBMB Life; 2007; 59, pp. 380-387. [DOI: https://dx.doi.org/10.1080/15216540701468954] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17613168]
169. Rubin, R.D.; Watson, P.D.; Duff, M.C.; Cohen, N.J. The Role of the Hippocampus in Flexible Cognition and Social Behavior. Front. Hum. Neurosci.; 2014; 8, 742. [DOI: https://dx.doi.org/10.3389/fnhum.2014.00742] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25324753]
170. Heijtz, R.D.; Wang, S.; Anuar, F.; Qian, Y.; Björkholm, B.; Samuelsson, A.; Hibberd, M.L.; Forssberg, H.; Pettersson, S. Normal Gut Microbiota Modulates Brain Development and Behavior. Proc. Natl. Acad. Sci. USA; 2011; 108, pp. 3047-3052. [DOI: https://dx.doi.org/10.1073/pnas.1010529108]
171. López-Moreno, A.; Torres-Sánchez, A.; Acuña, I.; Suárez, A.; Aguilera, M. Representative Bacillus Sp. AM1 from Gut Microbiota Harbor Versatile Molecular Pathways for Bisphenol A Biodegradation. Int. J. Mol. Sci.; 2021; 22, 4952. [DOI: https://dx.doi.org/10.3390/ijms22094952]
172. Feng, P.; Ye, Z.; Kakade, A.; Virk, A.K.; Li, X.; Liu, P. A Review on Gut Remediation of Selected Environmental Contaminants: Possible Roles of Probiotics and Gut Microbiota. Nutrients; 2019; 11, 22. [DOI: https://dx.doi.org/10.3390/nu11010022]
173. Kong, Q.; Wang, B.; Tian, P.; Li, X.; Zhao, J.; Zhang, H.; Chen, W.; Wang, G. Daily Intake of Lactobacillus Alleviates Autistic-like Behaviors by Ameliorating the 5-Hydroxytryptamine Metabolic Disorder in VPA-Treated Rats during Weaning and Sexual Maturation. Food Funct.; 2021; 12, pp. 2591-2604. [DOI: https://dx.doi.org/10.1039/D0FO02375B]
174. Javurek, A.B.; Spollen, W.G.; Johnson, S.A.; Bivens, N.J.; Bromert, K.H.; Givan, S.A.; Rosenfeld, C.S. Effects of Exposure to Bisphenol A and Ethinyl Estradiol on the Gut Microbiota of Parents and Their Offspring in a Rodent Model. Gut Microbes; 2016; 7, pp. 471-485. [DOI: https://dx.doi.org/10.1080/19490976.2016.1234657]
175. Farzi, A.; Fröhlich, E.E.; Holzer, P. Gut Microbiota and the Neuroendocrine System. Neurotherapeutics; 2018; 15, pp. 5-22. [DOI: https://dx.doi.org/10.1007/s13311-017-0600-5]
176. Rusch, J.A.; Layden, B.T.; Dugas, L.R. Signalling Cognition: The Gut Microbiota and Hypothalamic-Pituitary-Adrenal Axis. Front. Endocrinol.; 2023; 14, 1130689. [DOI: https://dx.doi.org/10.3389/fendo.2023.1130689]
177. Ohshima, M.; Ohno, S.; Nakajin, S. Inhibitory Effects of Some Possible Endocrine-Disrupting Chemicals on the Isozymes of Human 11beta-Hydroxysteroid Dehydrogenase and Expression of Their mRNA in Gonads and Adrenal Glands. Environ. Sci.; 2005; 12, pp. 219-230.
178. Kermath, B.A.; Thompson, L.M.; Jefferson, J.R.; Ward, M.H.B.; Gore, A.C. Transgenerational Effects of Prenatal Endocrine Disruption on Reproductive and Sociosexual Behaviors in Sprague Dawley Male and Female Rats. Toxics; 2022; 10, 47. [DOI: https://dx.doi.org/10.3390/toxics10020047] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/35202233]
179. Popescu, M.; Feldman, T.B.; Chitnis, T. Interplay Between Endocrine Disruptors and Immunity: Implications for Diseases of Autoreactive Etiology. Front. Pharmacol.; 2021; 12, 626107. [DOI: https://dx.doi.org/10.3389/fphar.2021.626107] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33833678]
180. Schug, T.T.; Janesick, A.; Blumberg, B.; Heindel, J.J. Endocrine Disrupting Chemicals and Disease Susceptibility. J. Steroid Biochem. Mol. Biol.; 2011; 127, pp. 204-215. [DOI: https://dx.doi.org/10.1016/j.jsbmb.2011.08.007] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21899826]
181. Skinner, M.K.; Anway, M.D.; Savenkova, M.I.; Gore, A.C.; Crews, D. Transgenerational Epigenetic Programming of the Brain Transcriptome and Anxiety Behavior. PLoS ONE; 2008; 3, e3745. [DOI: https://dx.doi.org/10.1371/journal.pone.0003745]
182. Tran, M.T.M.T.; Kuo, F.-C.; Low, J.-T.; Chuang, Y.-M.; Sultana, S.; Huang, W.-L.; Lin, Z.-Y.; Lin, G.-L.; Wu, C.-F.; Li, S.-S.
183. Van Cauwenbergh, O.; Di Serafino, A.; Tytgat, J.; Soubry, A. Transgenerational Epigenetic Effects from Male Exposure to Endocrine-Disrupting Compounds: A Systematic Review on Research in Mammals. Clin. Epigenet.; 2020; 12, 65. [DOI: https://dx.doi.org/10.1186/s13148-020-00845-1]
184. Crews, D.; Gillette, R.; Scarpino, S.V.; Manikkam, M.; Savenkova, M.I.; Skinner, M.K. Epigenetic Transgenerational Inheritance of Altered Stress Responses. Proc. Natl. Acad. Sci. USA; 2012; 109, pp. 9143-9148. [DOI: https://dx.doi.org/10.1073/pnas.1118514109]
185. Krishnan, K.; Rahman, S.; Hasbum, A.; Morales, D.; Thompson, L.M.; Crews, D.; Gore, A.C. Maternal Care Modulates Transgenerational Effects of Endocrine-Disrupting Chemicals on Offspring Pup Vocalizations and Adult Behaviors. Horm. Behav.; 2019; 107, pp. 96-109. [DOI: https://dx.doi.org/10.1016/j.yhbeh.2018.12.009]
186. Gillette, R.; Miller-Crews, I.; Skinner, M.K.; Crews, D. Distinct Actions of Ancestral Vinclozolin and Juvenile Stress on Neural Gene Expression in the Male Rat. Front. Genet.; 2015; 6, 56. [DOI: https://dx.doi.org/10.3389/fgene.2015.00056]
187. Gillette, R.; Miller-Crews, I.; Nilsson, E.E.; Skinner, M.K.; Gore, A.C.; Crews, D. Sexually Dimorphic Effects of Ancestral Exposure to Vinclozolin on Stress Reactivity in Rats. Endocrinology; 2014; 155, pp. 3853-3866. [DOI: https://dx.doi.org/10.1210/en.2014-1253]
188. Hatcher, K.M.; Willing, J.; Chiang, C.; Rattan, S.; Flaws, J.A.; Mahoney, M.M. Exposure to Di-(2-Ethylhexyl) Phthalate Transgenerationally Alters Anxiety-like Behavior and Amygdala Gene Expression in Adult Male and Female Mice. Physiol. Behav.; 2019; 207, pp. 7-14. [DOI: https://dx.doi.org/10.1016/j.physbeh.2019.04.018]
189. Martini, M.; Corces, V.G.; Rissman, E.F. Mini-Review: Epigenetic Mechanisms That Promote Transgenerational Actions of Endocrine Disrupting Chemicals: Applications to Behavioral Neuroendocrinology. Horm. Behav.; 2020; 119, 104677. [DOI: https://dx.doi.org/10.1016/j.yhbeh.2020.104677] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31927019]
190. Carbone, S.; Ponzo, O.J.; Gobetto, N.; Samaniego, Y.A.; Reynoso, R.; Moguilevsky, J.A.; Cutrera, R.A. Effect of Di(2-Ethylhexyl) Phthalate on the Neuroendocrine Regulation of Reproduction in Adult Male Rats and Its Relationship to Anxiogenic Behavior: Participation of GABAergic System. Hum. Exp. Toxicol.; 2019; 38, pp. 25-35. [DOI: https://dx.doi.org/10.1177/0960327118774868] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29774754]
191. Chen, Y.C.; Yu, M.L.; Rogan, W.J.; Gladen, B.C.; Hsu, C.C. A 6-Year Follow-up of Behavior and Activity Disorders in the Taiwan Yu-Cheng Children. Am. J. Public Health; 1994; 84, pp. 415-421. [DOI: https://dx.doi.org/10.2105/AJPH.84.3.415] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/8129058]
192. Freire, C.; Amaya, E.; Gil, F.; Fernández, M.F.; Murcia, M.; Llop, S.; Andiarena, A.; Aurrekoetxea, J.; Bustamante, M.; Guxens, M.
193. Kim, S.; Eom, S.; Kim, H.-J.; Lee, J.J.; Choi, G.; Choi, S.; Kim, S.; Kim, S.Y.; Cho, G.; Kim, Y.D.
194. Vuong, A.M.; Yolton, K.; Xie, C.; Webster, G.M.; Sjödin, A.; Braun, J.M.; Dietrich, K.N.; Lanphear, B.P.; Chen, A. Childhood Polybrominated Diphenyl Ether (PBDE) Exposure and Neurobehavior in Children at 8 Years. Environ. Res.; 2017; 158, pp. 677-684. [DOI: https://dx.doi.org/10.1016/j.envres.2017.07.028]
195. Zhang, Q.; Chen, X.-Z.; Huang, X.; Wang, M.; Wu, J. The Association between Prenatal Exposure to Phthalates and Cognition and Neurobehavior of Children-Evidence from Birth Cohorts. NeuroToxicology; 2019; 73, pp. 199-212. [DOI: https://dx.doi.org/10.1016/j.neuro.2019.04.007]
196. León-Olea, M.; Martyniuk, C.J.; Orlando, E.F.; Ottinger, M.A.; Rosenfeld, C.S.; Wolstenholme, J.T.; Trudeau, V.L. Current Concepts in Neuroendocrine Disruption. Gen. Comp. Endocrinol.; 2014; 203, pp. 158-173. [DOI: https://dx.doi.org/10.1016/j.ygcen.2014.02.005] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24530523]
197. Mendola, P.; Buck, G.M.; Sever, L.E.; Zielezny, M.; Vena, J.E. Consumption of PCB-Contaminated Freshwater Fish and Shortened Menstrual Cycle Length. Am. J. Epidemiol.; 1997; 146, pp. 955-960. [DOI: https://dx.doi.org/10.1093/oxfordjournals.aje.a009222] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/9400337]
198. Dallaire, R.; Dewailly, É.; Ayotte, P.; Forget-Dubois, N.; Jacobson, S.W.; Jacobson, J.L.; Muckle, G. Exposure to Organochlorines and Mercury through Fish and Marine Mammal Consumption: Associations with Growth and Duration of Gestation among Inuit Newborns. Environ. Int.; 2013; 54, pp. 85-91. [DOI: https://dx.doi.org/10.1016/j.envint.2013.01.013] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23422685]
199. Buck Louis, G.M. Persistent Environmental Pollutants and Couple Fecundity: An Overview. Reproduction; 2014; 147, pp. R97-R104. [DOI: https://dx.doi.org/10.1530/REP-13-0472]
200. Fourrier, J.; Deschamps, M.; Droin, L.; Alaux, C.; Fortini, D.; Beslay, D.; Conte, Y.L.; Devillers, J.; Aupinel, P.; Decourtye, A. Larval Exposure to the Juvenile Hormone Analog Pyriproxyfen Disrupts Acceptance of and Social Behavior Performance in Adult Honeybees. PLoS ONE; 2015; 10, e0132985. [DOI: https://dx.doi.org/10.1371/journal.pone.0132985]
201. Nilsen, E.; Smalling, K.L.; Ahrens, L.; Gros, M.; Miglioranza, K.S.B.; Picó, Y.; Schoenfuss, H.L. Critical Review: Grand Challenges in Assessing the Adverse Effects of Contaminants of Emerging Concern on Aquatic Food Webs. Environ. Toxicol. Chem.; 2019; 38, pp. 46-60. [DOI: https://dx.doi.org/10.1002/etc.4290]
202. Ward, J.L.; Korn, V.; Auxier, A.N.; Schoenfuss, H.L. Temperature and Estrogen Alter Predator–Prey Interactions between Fish Species. Integr. Org. Biol.; 2020; 2, obaa008. [DOI: https://dx.doi.org/10.1093/iob/obaa008]
203. Eikenaar, C.; Müller, F.; Leutgeb, C.; Hessler, S.; Lebus, K.; Taylor, P.D.; Schmaljohann, H. Corticosterone and Timing of Migratory Departure in a Songbird. Proc. Biol. Sci.; 2017; 284, 20162300. [DOI: https://dx.doi.org/10.1098/rspb.2016.2300]
204. Deem, S.L.; Holliday, D.K. Chapter 21—Impacts from Endocrine Disrupting Chemicals on Wildlife Health—A One Health Challenge. Fowler’ s Zoo and Wild Animal Medicine Current Therapy, Volume 10; Miller, E.; Lamberski, N.; Calle, P. W.B. Saunders: New Delhi, India, 2023; pp. 131-136. ISBN 978-0-323-82852-9
205. Godfray, H.C.J.; Stephens, A.E.A.; Jepson, P.D.; Jobling, S.; Johnson, A.C.; Matthiessen, P.; Sumpter, J.P.; Tyler, C.R.; McLean, A.R. A Restatement of the Natural Science Evidence Base on the Effects of Endocrine Disrupting Chemicals on Wildlife. Proc. R. Soc. B Biol. Sci.; 2019; 286, 20182416. [DOI: https://dx.doi.org/10.1098/rspb.2018.2416]
206. Zhou, J.; Cai, Z.-H.; Zhu, X.-S. Are Endocrine Disruptors among the Causes of the Deterioration of Aquatic Biodiversity?. Integr. Environ. Assess. Manag.; 2010; 6, pp. 492-498. [DOI: https://dx.doi.org/10.1002/ieam.47]
207. Moosa, A.; Shu, H.; Sarachana, T.; Hu, V.W. Are Endocrine Disrupting Compounds Environmental Risk Factors for Autism Spectrum Disorder?. Horm. Behav.; 2018; 101, pp. 13-21. [DOI: https://dx.doi.org/10.1016/j.yhbeh.2017.10.003]
208. Jankowska, A.; Polańska, K.; Koch, H.M.; Pälmke, C.; Waszkowska, M.; Stańczak, A.; Wesołowska, E.; Hanke, W.; Bose-O’Reilly, S.; Calamandrei, G.
209. Chevrier, C.; Warembourg, C.; Le Maner-Idrissi, G.; Lacroix, A.; Dardier, V.; Le Sourn-Bissaoui, S.; Rouget, F.; Monfort, C.; Gaudreau, E.; Mercier, F.
210. Cunha, Y.G.d.O.; Amaral, G.C.B.d.; Felix, A.A.; Blumberg, B.; Amato, A.A. Early-Life Exposure to Endocrine-Disrupting Chemicals and Autistic Traits in Childhood and Adolescence: A Systematic Review of Epidemiological Studies. Front. Endocrinol.; 2023; 14, 1184546. [DOI: https://dx.doi.org/10.3389/fendo.2023.1184546] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/37361542]
211. Coady, K.K.; Biever, R.C.; Denslow, N.D.; Gross, M.; Guiney, P.D.; Holbech, H.; Karouna-Renier, N.K.; Katsiadaki, I.; Krueger, H.; Levine, S.L.
212. Lagunas-Rangel, F.A.; Linnea-Niemi, J.V.; Kudłak, B.; Williams, M.J.; Jönsson, J.; Schiöth, H.B. Role of the Synergistic Interactions of Environmental Pollutants in the Development of Cancer. Geohealth; 2022; 6, e2021GH000552. [DOI: https://dx.doi.org/10.1029/2021GH000552]
213. Vandenberg, L.N. Non-Monotonic Dose Responses in Studies of Endocrine Disrupting Chemicals: Bisphenol A as a Case Study. Dose Response; 2013; 12, pp. 259-276. [DOI: https://dx.doi.org/10.2203/dose-response.13-020.Vandenberg]
214. Burton, N.O.; Greer, E.L. Multigenerational Epigenetic Inheritance: Transmitting Information across Generations. Semin. Cell Dev. Biol.; 2022; 127, pp. 121-132. [DOI: https://dx.doi.org/10.1016/j.semcdb.2021.08.006]
215. Chakravarty, A.K.; Jarosz, D.F. More than Just a Phase: Prions at the Crossroads of Epigenetic Inheritance and Evolutionary Change. J. Mol. Biol.; 2018; 430, pp. 4607-4618. [DOI: https://dx.doi.org/10.1016/j.jmb.2018.07.017]
216. Peng, D.; Wang, C.; Li, K.-L.; Gan, Z.-X.; Li, Y.-H.; Wang, H.-W.; Li, Q.-Y.; Liu, X.-W.; Sun, H.-Y.; Jing, Y.-Y.
217. Kumar, V.; Deepika, D.; Sharma, R.P. Integrated Translation Framework for Endocrine Disruptors in the Area of Computational Toxicology. Challenges in Endocrine Disruptor Toxicology and Risk Assessment; The Royal Society of Chemistry: Cambridge, UK, 2020.
218. Bornehag, C.-G.; Engdahl, E.; Unenge Hallerbäck, M.; Wikström, S.; Lindh, C.; Rüegg, J.; Tanner, E.; Gennings, C. Prenatal Exposure to Bisphenols and Cognitive Function in Children at 7 Years of Age in the Swedish SELMA Study. Environ. Int.; 2021; 150, 106433. [DOI: https://dx.doi.org/10.1016/j.envint.2021.106433]
219. Özel, F.; Stratmann, M.; Lindh, C.; Gennings, C.; Bornehag, C.-G.; Rüegg, J. Prenatal Exposure to Phthalates and Gender-Specific Play Behavior at Seven Years of Age in the SELMA Study. Environ. Int.; 2023; 178, 108029. [DOI: https://dx.doi.org/10.1016/j.envint.2023.108029]
220. Hyland, C.; Mora, A.M.; Kogut, K.; Calafat, A.M.; Harley, K.; Deardorff, J.; Holland, N.; Eskenazi, B.; Sagiv, S.K. Prenatal Exposure to Phthalates and Neurodevelopment in the CHAMACOS Cohort. Environ. Health Perspect.; 2019; 127, 107010. [DOI: https://dx.doi.org/10.1289/EHP5165]
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.